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ABSTRACT 
Micellar electrokinetic chromatography (MEKC), one of the major capillary 
electrophoresis (CE) modes, has been interfaced to mass spectrometry (MS) to provide high 
sensitivity and selectivity for analysis of chiral compounds. The research in this dissertation 
presents the development of novel polymeric glucopyranoside based molecular micelles (MoMs) 
(aka. polymeric surfactants) and their application in chiral MEKC-MS.  
Chapter 1 is a review of chiral CE-MS - in the period 2010-2015.  In this chapter, the 
fundamental of chiral CE and CE-MS is illustrated and the recent developments of chiral 
selectors and their applications in chiral EKC-MS, CEC-MS and MEKC-MS are discussed in 
details.  
Chapter 2 introduces the development of a novel polymeric α-D-glucopyranoside based 
surfactants, n-alkyl-α-D-glucopyranoside 4,6-hydrogen phosphate, sodium salt. In this chapter, 
polymeric α-D-glucopyranoside-based surfactants with different chain length and head groups 
have been successfully synthesized, characterized and applied as compatible chiral selector in 
MEKC-ESI-MS/MS. or the enantioseparation of ephedrines and β-blockers.   
Chapter 3 continues to describe the employment of polymeric glucopyranoside based 
surfactants as chiral selector in MEKC-MS/MS. The polymeric β-D-glucopyranoside based 
surfactants, containing charged head groups such as n-alkyl β-D-glucopyranoside 4,6-hydrogen 
phosphate, sodium salt and n-alkyl β-D-glucopyranoside 6-hydrogen sulfate, monosodium salt 
were able to enantioseparate 21 cationic drugs and 8 binaphthyl atropisomers (BAIs) in MEKC-
MS/MS, which promises to open up the possibility of turning an analytical technique into high 
throughput screening of chiral compounds. Physicochemical properties and enantioseparation 
capability of polymeric β-D-glucopyranoside based surfactants with different head groups and 
chain lengths were compared.  Moreover, the comparison of polymeric α- and β-D-
glucopyranoside 4,6-hydrogen phosphate, sodium salt were further explored with regard to 
enantioseparations of ephedrine alkaloids and b-blockers.  The concept of multiplex chiral 
MEKC-MS for high throughput quantitation is demonstrated for the first time in scientific 
literature. 
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A Review: Chiral Capillary Electrophoresis-Mass Spectrometry:  Developments and 
Applications in the Period 2010-2015 
 
 
 
 
 
  
2 
The sensitive detection of chiral compounds in biological samples represents a significant 
challenge and is currently considered a bottleneck in many chiral analysis projects. The use of a 
of chiral selectors such as modified cyclodextrins (CDs) and amino acid based polymeric 
surfactants (a.k.a. molecular micelles, MoMs) in electrokinetic chromatography (EKC), micellar 
electrokinetic chromatography (MEKC) and capillary electrochromatography (CEC) have shown 
to be successful for various enantioseparation modes in capillary electrophoresis (CE). Chiral CE 
with mass spectrometry (MS) detection can largely improve the limit of detection. Therefore, in 
chiral CE-MS chiral compounds are not only enantioseparated with high efficiency and high 
chiral selectivity but also high sensitivity. In this review, major chiral CE-MS modes, separation 
and detection principles as well as a brief history are introduced. Next, recent developments and 
progress of chiral CE-MS dating from Jan. 2010 to Sep. 2015 are described. The various 
achievements, biomedical and clinical applications of CDs and MoMs in EKC-MS, MEKC-MS 
and CEC-MS are discussed. Finally, conclusions and future prospects of CE-MS in chiral 
analysis are drafted. 
 
1.1. Introduction  
Although non-chromatographic methods (e.g., polarimetry, nuclear magnetic resonance, 
isotopic dilution, calorimetry and enzyme techniques) could be used for enantiomeric analysis, 
these methods need pure samples. Chromatographic techniques such as gas chromatography 
(GC), high performance liquid chromatography (HPLC), and capillary electrophoresis (CE) does 
not require pure samples and efficiently quantitate multiple chiral compounds. Chiral HPLC and 
CE have proven to be better methods than chiral GC for enantiomeric analysis of non-volatile 
compounds. Separation systems such as HPLC or SFC may rival or complement CE but the 
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options are available through numerous modes of CE [e.g., micellar electrokinetic 
chromatography, (MEKC) and capillary electrochromatography, (CEC)]. These modes if 
properly tuned provide high efficiency and resolution like capillary zone electrophoresis (CZE) 
and high selectivity like HPLC. Furthermore, it is much easier and cost effective to employ 
expensive and exotic chiral selectors (either added as pseudophase in the CE buffer or as a real 
stationary phase in a capillary column). 
Chiral separations in CE was first performed in 1985 using ligand exchange systems [1]. 
Currently, chiral CE is considered equally competitive to chiral HPLC and chiral SFC 
techniques. However, the development of sensitive detection methodologies for CE for trace 
levels detection of chiral compounds is currently one of the most challenging issue in chiral CE.   
This is because there is a growing need to measure changes at nanomolar to picomolar levels of  
a parent chiral drug and its metabolites (aka. chiral metabonomics) in biological fluids and 
tissues for therapeutics and early disease diagnostics.   
As mentioned above, despite of the attractive properties of CE, sensitivity is the critical 
point in chiral analysis by UV detection as it hardly meets the requirements for trace analysis of 
chiral compounds in biological samples due to short optical path-length of the capillary.  Laser 
induced fluorescence might offer enhanced detection, but is limited to only few chiral 
compounds.  Recent emergence of chiral CE-MS offer new perspectives into the analysis of 
chiral molecules important in human diets, drugs and diseases.   Thus, the  technical marriage 
between CE and MS particularly for sensitive and routine analysis of chiral compounds in real 
biological matrices could provide major breakthrough for several important reasons: (i) solve the 
identification problems of unknown chiral non-chromophoric or chromophoric compounds in 
real samples, (ii) development of modern MS, MS-MS and MSn instruments provide better 
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accuracy, mass resolution, structural information about the unknown metabolites of a parent 
drug, (iii) reduce matrix effects of biological samples when the co-migrating peaks are baseline 
resolved, (iv) provide high throughput for analysis of multiple chiral compounds.   In addition, 
not only selective, sensitive and specific CE-MS schemes are needed but also high purity chiral 
reagents and rugged capillary columns, will provide better RSD for run-to-run and batch to batch 
reproducibility of chiral pseudophases and stationary phases, respectively.  Multiplex capability 
will allow high throughput quantitation, which is very much needed to advance the field.   
Various Modes of CE-MS 
Chiral CE-MS is a generic term and depending on format and type of chiral selectors 
used, the technology of CE-MS is segmented into several separation techniques. Examples of 
chiral CE-MS modes includes: (a) chiral capillary zone electrophoresis (CCZE)-MS; [2-4] (b) 
chiral electrokinetic chromatography (CEKC)-MS; [5-7] (c) chiral micellar electrokinetic 
chromatography (CMEKC)-MS; [8-9] and (d) capillary electrochromato-graphy (CEC)-MS [10].  
The first mode of CCZEseparate enantiomeric ions based on the same principle as 
conventional CE upon application of applied voltage except that the volatile buffer contains 
chiral selectors such as native [(α-, β-, γ- CDs] or derivatized (dimethyl-, trimethyl-,  
hydroxypropyl--CDs) at very low concentra-tions [1].  The aforementioned neutral chiral 
selectors, which moves at the rate of electroosmotic flow (EOF) are only useful for separation 
and detection of charged chiral enantiomers.  It should be noted that there is no electrophoretic 
mobility difference between the two enantiomers, only the difference in enantioselective 
interactions with the chiral selector may create a difference in apparent effective mobility 
between complexed and the uncomplexed form of the enantiomer with the neutral chiral 
selectors.  Because efficiencies are higher, even small difference in mobility leads to 
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enantioseparation. If we have a mixture of cation and anionic enantiomeric compounds then the 
two chiral cations with the largest charge to mass ratio (q/m) will elute first, followed by chiral 
cations with reduced ratios, anions with smaller q/m and finally anions  elutes with greater ratios 
before their ionization in the electrospray.   
The CEKC-MS mode is similar to CCZE-MS  except charged chiral reagents (positively 
and negatively charged CDs, crown ethers, macrocylic  antibiotics and proteins) now act as 
moving pseudostationary phase (PSP), which  can be used to separate and detect both neutral and 
charged chiral analytes by MS.  In CMEKC, unpoloymerized micelles or polymerizable charged 
surfactants forming molecular micelles (MoMs) are added to the volatile buffer to achieve chiral 
separations.   Nevertheless, the general requirements for the use of neutral or charged chiral 
reagents for all three modes (i.e.,CCZE-MS, CEKC-MS and CMEKC-MS) are: (a) sufficient 
solubility in the buffer without generating too much background current i.e., < 50 µm; (b) 
compatibility with MS detection ; (c) high molecular weight but low viscosity allowing faster 
elution of enantiomers and; (d) less spectral clutter do not produce interfering MS signal in m/z 
range of interest.  
The fourth and final mode is CCEC in which retention occurs due to combination of 
electrophoretic and chromatographic separation principles.  The three different fabrication 
formats of stationary phase in CCEC are: (a) packed, (b) open tubular and (c) monolithic 
columns.   In packed column CEC, the separation capillary is homo-geneously packed with 
chiral particles under high pressures and frits or fritless columns can be fabricated to retain the 
chiral particles inside the column.  In open tubular CEC, the chiral selector is chemically bonded 
or physically coated to the inner core of the capillary tube, whereas in monolithic format a single 
piece of polymerized chiral monolith is formed inside the pretreated capillary.  Notably, all three 
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version of CCEC avoids the introduction of low molecular weight chiral selector for MS 
detection. 
The MS coupled to CE provides not only very sensitive analysis but also structural 
information. Since its first successful application for chiral separation in 1995 [11], the 
development of chiral CE-MS has continued to expand and grow. Although the application of 
chiral CZE-MS and EKC-MS is still not widely used due to the interference caused by relatively 
large concentrations of nonvolatile chiral selectors entering the MS, considerable progress has 
been made to circumvent these disadvantages in the past few years through instrumentation 
development and interface design.  Thus, hyphenation of CE to MS has been attempted with at 
least four interface designs: (a) sheath flowing through a triple tube nebulizer, (b) porous tip 
sheathless, (c) micro flow through vial, and (c) EOF driven sprayer using borosilicate glass 
combined with sheath flow.  In addition to conventional ESI ionization source, atmospheric 
pressure photoionization (APPI) has been used to detect neutral chiral compounds in the gas 
phase.  The type of mass analyzers (QTOF, TOF, ion trap, single and tripe quadrupoles have 
been used [12-15]. Among them, sheath flow interface with electrospray ionization (ESI), and 
quadrupole MS have been reported for majority of enantioselective analysis. 
In this review, we focused our critques on recent developments and applications of chiral 
separation using chiral EKC-MS, MEKC-MS and CEC-MS from 2010 up to 2015. This review 
first presents the separation principle in various modes of chiral CE-MS.  Next, chiral selectors 
used in chiral EKC-MS, chiral MEKC-MS and chiral CEC-MS are reviewed in details that cover 
analysis of chiral compounds important in pharmaceutical, agricultural and environmental fields.  
The application at low levels of chiral drugs in biological samples is discussed. Finally, the 
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review ends with some general concluding remarks and future prospects of these hyphenated 
modes for various applications related to enantiomeric analysis.  
1.2. Chiral CE-MS 
1.2.1 A Brief Theory of CE  
The separation of different charged compounds with various charge to mass ratio in 
capillary zone electrophoresis (CZE) is based on the electrophoretic mobility (µe) difference 
under a given electric field (E). The relationship of the solute velocity (v) and its µe can be 
expressed as:               
v = µe E          (1) 
In CE, v can be replaced by l/t, where l is the effective capillary length, t is the migration 
time. Similarly, E can be replaced by V/L, where Vis applied voltage and L is the total length of 
the capillary. Therefore, equation (1) can be described as following equation (2) to calculate 
experimental apparent mobility µa.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
 
                                                 µa= lL/(tV)         (2) 
 
 
1.2.2 Separation principles in CEKC-MS  
The coupling of EKC to MS was first introduced by Schulte et al. for chiral separations 
[16].  In CEKC-MS, the enantioseparation is achieved by adding the chiral selectors (aka.PSP) 
into the volatile background electrolyte (BGE). The difference of enantioselective noncovalent 
interactions between enantiomers and chiral PSP leads to the differences in apparent 
electrophoretic mobility, consequently enantioseparation.  In contrast to the most basic mode of 
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CE-MS, charged CDs, macrocyclic antibiotics or crown ethers have been used to separate both 
charged and neutral chiral compounds in EKC-MS.  The major intermolecular interactions 
between analyte and chiral selector are inclusion, hydrophobic, hydrogen bonding, electrostratic 
and van der Walls interactions with the moving charged PSP.  
Fig. 1.1 illustrates the separation principle of CEKC with anionic charged CDs.  In this 
case, the capillary wall is negatively charged due to almost complete deprotonation of the silanol 
groups.  The EOF, which is the major pulling force for the solute, is toward cathodic end.  When 
the capillary is filled with a negatively charged chiral selector (e.g., sulfated-β-CD),   the 
mobility of PSP (µpsp) is typically high towards anodic end, and is fairly large because of low 
molecular weight.  If the mobility of EOF (µEOF) is larger than µpsp, the chiral selector will elute 
at the time tpsp at the MS detection end.  However, if µEOF is smaller than µpsp, the chiral selector 
will never elute at the MS end. The neutral chiral analytes partition between the PSP and the 
surrounding aqueous phase, depending on hydrophobicity, hydrogen bonding and van der Walls 
etc.   Very non-polar neutral chiral analyte (N1) with mobility μ1 partition into the chiral selector 
and will elute at or near the tpsp. On the other hand, very polar neutral chiral analyte (N2) with 
mobility μ2 stays in the surrounding phase and will co-elute with EOF or sometimes elute before 
EOF.  Cationic chiral analyte (C) with mobility µc will elute later than the neutral chiral analyte 
due to the strong electrostatic attraction with the negatively charged PSP.  Since anionic chiral 
analyte (A) with mobility µA has the least interaction with the negatively charged PSP,  ait will 
remain mostly in the bulk solution resulting in fastest elution. 
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Fig.1.1 Schematic of the separation principle in chiral EKC using negatively charged 
cyclodextrin as chiral selector. The μEOF is the mobility of EOF; μPSP (complexed) is the mobility 
of anionic cyclodextrin complexed with the analyte; μPSP(free) is the mobility of the free form of 
anionic cyclodextrin; μC is the mobility of the cationic chiral analyte; μ1 is the mobility of the 
non-polar neutral chiral analyte; μ2 is the mobility of the polar neutral chiral analyte; μA is the 
mobility of the anionic chiral analyte. The detector end is positioned at the electrospray end of 
the mass spectrometer where the flowing sheath liquid combines the effluent from the CE 
capillary protruding from the nebulizer (acting as a outlet vial) to complete the electric circuit. 
 
 
 
As mentioned earlier, EKC utilizes charged chiral selector as PSP.  Therefore, EKC is 
fundamentally a type of pseudo-chromatography and it has almost the same theory as traditional 
chromatography [17]. The retention factor (k’) in CEKC is given by the following equation (3) as 
the moles (n) of solutes in PSP divided by the moles of solutes (n) in the mobile phase: 
 
                                       k’= npsp/naq                  (3) 
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The k’ relates to the migration time of the analyte and PSP, which can be described by the 
following equation (4):  
 
                                                                                                  (4)                                                                                                 
 
 
Where tR is the migration time of the analyte, t0 is the migration time of EOF marker, tpsp is the 
migration time of the PSP. When the mobility of PSP is very large and is in direction opposite to 
EOF , i.e., when tpsp is equal to infinity, equation (4) can be simplified as follows:  
                                                                                                        
                                                                                                      (5) 
 
In CEKC, only the difference in enantioselective interactions with the chiral selector may create 
a difference in apparent effective mobility, which leads to the enantioseparation.  The Rs of two 
enantiomeric peaks in CEKC is related to selectivity (α), capacity factor(k’) and efficiency (N) 
by the following fundamental equation [18,19]: 
 
                                                                                                                           (6) 
 
 
While the first three parenthetical terms in equation (6) are the same as those expressed in 
conventional chromatography, the fourth parenthetical term accounts for the effect of limited 
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migration range, and is unique to EKC.  If the mobility of anionic PSP reaches infinite, it will 
never elute at the cathodic end, allowing equation (6) to be modified as follows: 
 
                                                                                                     (7) 
 
 
When CEKC is hyphenated to MS detection, combination of volatile BGE and low 
concentration of chiral selector is employed. Alternatively, partial filling technique and counter 
current migration can be used to avoid the contamination of the ion source in ESI-MS.  
 
1.2.3  Principles of CMEKC-MS 
The separation mechanism of CMEKC is the same as CEKC, which is discussed in 
section 1.2.2 except that high molecular weight micelles (aka. molecular micelles, MoM) are 
used as PSP.  In CMEKC, the capacity factor (k’) can also be related to the phase ratio, which is 
the distribution of the enantiomers between micellar phase and the aqueous phase: 
                                         k’ = K (Vm/Vaq)                   (8) 
where K is the distribution coefficient and Vm/Vaq is the phase ratio of the micellar phase over 
the surrounding aqueous phase. The Vm/Vaq ratio can be calculated by following equation (9):  
 
                                                                               (9) 
where K is the partial specific volume of the molecular micelles and Cpsp represents the 
concentration of PSP; CMC is the critical micellar concentration. Replacing the Vm/Vaq ratio 
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with equation (9), the capacity factor can be related to the micellar concentration in the following 
equation (10):  
 
                                                                                                     (10) 
 
Because the CMC of MoM is zero, above equation (10) can be simplified as follows: 
 
                                                                                            (11) 
   
 
Since      is a very small number, the denominator is usually negligible. For example, if  of 
SDS is 0.247 L/mol and the concentration of SDS used is usually 0.1 mol/L, the denominator is 
0.9753. Therefore, above equation can be described as below: 
                                                                                              (12) 
 
Fig. 1.2 shows the separation principle of CMEKC with anionic chiral MoM The 
molecular weight and the mobility of the MoM (µMoM) is typically much higher compared to 
small molecular weight chiral selectors (e.g., charged CDs and crown ethers).  Therefore, 
detection of µMoM toward cathodic end is rather difficult.   When µEOF >>µMoM, the chiral MoM 
will finally elute but at a much longer time than a typical tmc. observed with unpolymerized low 
molecular weight chiral selectors, or the chiral MoM will never elute at the cathodic end of the 
capillary depending on the type of the chiral MoM used.  
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The very polar and hydrophilic neutral chiral analyte (   ) with mobility µ1 only interacts 
with the micellar surface through dipole interactions and therefore co-elute with EOF or 
sometimes elutes before EOF.  This is followed by the moderately hydrophobic solutes 
(containing both polar and hydrophobic groups), which will interact at the palisade layer of the 
micelle (  ) and elutes with mobility µ2.  Finally, hydrophobic neutral compounds, which do not 
contain any polar groups interacts with the core of the micelles (♥) and elute last with a mobility 
µ3. Thus, in CMEKC, analytes with different polarities will be separated according to the 
combination of dipole-dipole, hydrophobic and hydrogen bonding interactions with the MoM. 
Cationic chiral analyte (C+)-type containing hydrophobic and hydrogen bonding groups with 
mobility µc
+ will elute the very last because of the strong electrostatic binding with the 
negatively charged MoM.   In addition, dipole-dipole interactions and hydrophobic interactions 
will also occur with C+ type chiral analytes.  The anionic chiral analyte (A-)-type with mobility 
µA
- will elute faster than the moderately hydrophobic or highly hydrophobic neutral compounds 
and may enantioseparate only if the combined effect of hydrogen bonding and hydrophobic 
interactions are strong enough to overcome the electrostatic repulsions with the negatively 
charged MoM.   
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Fig.1.2 Schematic of the separation principle in chiral MEKC using high molecular-weight 
molecular micelle (MoM) as a pseudostationary phase. The open five-point star, open heart and 
open triangle represents the free form of the enantiomer of neutral chiral analytes; the solid five-
point star, solid heart and solid triangle represents the complexed form of the enantiomer of 
neutral chiral anlaytes; C, C’ are the complexed and free forms of enantiomers of cationic chiral 
analyte, respectively; A, A’ are the complexed and free forms of enantiomers of anionic chiral 
analyte, respectively; μMoM(complexed) is the mobility of the anionic MoM complexed with the 
analyte; μMoM(free) is the mobility of the free form of anionic polymeric molecular micelles 
 
 
Although MEKC based methodologies using unpolymerized chiral micelles have been 
used for chiral separation, there are severe limitations when it is coupled to MS.  First, to achieve 
high enantioselectivity the unpolymerized surfactant had to be used at much higher concentration 
to allow micelle formation, which in turn suppress the ESI-MS signal and contaminates the mass 
analyzer.  Second, the use of higher concentration of organic solvent in the running buffer 
(required to improve the solubility of hydrophobic chiral analyte) destroys the micelle formation.  
Thus, micellar destruction may affect the chiral recognition of hydrophobic solutes and 
essentially reduces the chiral window for simultaneous enantioseparation of parent drugs and its 
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metabolites.   Therefore, when CMEKC is hyphenated to MS, high molecular weight MoM 
having zero CMC are always considered as the best option.  In addition, high concentration of 
organic solvent (e.g., up to 60% of methanol and 40% acetonitrile) could be used without any 
concerns on micellar destruction or decrease in separation selectivity of highly hydrophobic and 
neutral polyaromatic hydrocarbons [20].  Recent studies indicated that covalently bonded MoM 
can be used conveniently at concentrations as high as 50 mM without any ESI-MS signal 
suppression for multiple chiral separation of complex mixtures [21]. 
1.2.4 Principles of CCEC-MS  
Besides MEKC-MS, the other major CE-MS mode is CCEC-MS, which has been 
extensively used in the separation and detection of chiral compounds. CCEC-MS is a hybrid 
technique combining high selectivity of HPLCand high efficiency of CZE.  There are three 
different types of CCEC.  In open tubular (OT)-CEC-MS, a chiral stationary phase (CSP) is 
formed by either physically or chemically coating or bonding the chiral selector to the capillary 
wall.  In packed column CCEC-MS, a separation capillary is slurry packed with particles using 
externally [22] or internally tapered [23] column  or simply using a fritless column [24] with an 
inert packing material containing as chiral selector.   In the third type of chiral CEC, a 
continuous rod or chiral monolith is formed inside the coated capillary by in-situ polymerization 
methods.  Nevertheless, all of these three aforementioned formats of chiral CEC avoid the 
introduction of chiral selector in MS making this mode a promising technique for analysis of 
trace levels of chiral drugs and metabolites in biological samples.   
As shown in Fig.1.3A, the EOF in coated capillaries of OT-CEC column depends 
strongly on the negative charges on the covalently attached bonded groups.  The separation of 
two enantiomers A and A’ occurs due to difference in distribution equilibria of the enantiomer 
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pair between the mobile phase and chemically bonded CSP. In packed-column CCEC, the chiral 
selector is bonded to a silica support which is packed into the capillary (Fig.1.1.3B). A single frit 
internally tapered column is packed with chiral particles and the two enantiomers A and A’ are 
separated according to their intermolecular interactions such as π–π interaction, hydrogen 
bonding with the chiral packing.  Within monolithic capillary column, the anionic CSP forms a 
porous polymer network anchored to the capillary walls (Fig.1.1.3C).After the generation of 
EOF by the anionic crosslinked monomers of the CSP, the two enantiomers of the chiral analyte, 
A and A’ are separated based on the combination of electrostatic, ion-pairing and hydrophobic 
interactions between CSP and the analytes.   
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.3 Separation mechanism in chiral CEC using open-tubular column (A), packed column (B) 
and monolithic column (C). A and A’ represent the two enantiomers of the chiral analyte 
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1.2.5 Comparison of chiral OT-CEC-MS, packed column CEC-MS and monolithic CEC-
MS 
OT-CEC columns have much simpler and less time-consuming coating procedures than 
packed columns but they suffer from small sample capacity and limited resolution due to the 
small surface area of the coating.  When OT-CEC is hyphenated to MS detection, the MS source 
is likely to be contaminated if the coating of fused silica capillary is unstable over time. Tapered 
packed columns provide better enantiomeric selectively and higher sample loading capacity 
compared to conventional OT-CEC.  However, when such columns, in particular externally 
tapered column is coupled to MS, the outlet end of the CEC column exposed to the nebulizing 
end of the MS instrument will cause bubble formation, which results in several drawbacks such 
as irreproducible retention times and even current breakdown. The major advantage of 
monolithic CCEC is that it can be interfaced to MS easily without limitations of packing 
procedure and less prone to bubble formations. The main issue is to find the appropriate 
polymerization conditions, leading to good porosity and permeability without compromising 
chiral selectivity.   
1.3. Applications of chiral selectors in CE-MS 
The applicability of chiral selectors for CE-MS in analysis of various chiral compounds 
was demonstrated in 15 publications in the period from Jan 2010 to July 2015. A summary of 
these studies listed in Table 1 provides information about the type of chiral selector and 
enantiomers analyzed, the type of background electrolyte and MS conditions as well as the type 
of capillary used.  In the following sections, the applications of modes of CE-MS using the 
various types and formats of chiral selectors are discussed. 
 
18 
 
 
Analyte enantiomers chiral selector used BGE MS conditions capillary used Refs 
duloxetine 
(2-hydroxypropyl)-β-
CD 150 mM  NH4CO2H, pH 3.0 
sheath liquid: 80:20 (v/v) MeOH/H2O with 0.1% (v/v) of  
HCOOH at 3.3 μL/min. Nebulizer and the drying gas :3 psi and 
5 L/min at 200 
oC.   ESI source in the positive ion mode at −4.5 
kV with an end plate of −500 V. 
fused-silica 
capillary 1 
glutethimide, amino-
glutethimide,warfarin and 
2,2,2-trifluoro-1-(9-anthryl) 
ethanol,benzoin 
CDMPC and 
CDMPC-SO3 
70% ACN, 5 mM 
NH4COOH, pH 3.5 
sheath liquid, MeOH/H2O (90:10, v/v) with 50 mM NH4OAc at 
5.0 μL/min; capillary voltage, +3000 V; 
fragmentor voltage, 80 V; drying gas flow rate, 5 L/min; drying 
gas temperature, 130 
o
C; nebulizer pressure, 4 psi. 
single inlet frit 
packed column 23 
aminoglutethimide, 
derivatized methylamine 
and dimethylamine,Brij 30 
and Brij 56 non-ionic 
surfactant 
sulfated cellulose 
dimethylphenylcarba
mate;mixed mode 
hydrophobic and 
anion exchange 
C6/SAX 
stationary phase;C18 
stationary phase 
70% ACN 5 mM 
NH4CO2H, pH 3.5;5 mM 
NH4COOH, pH 3.0; 80% 
ACN, 5 mM Tris, pH 8.0 
sheath liquid : 90% MeOH 50 mM NH4OAc at 5 μL/min.  
nebulizer pressure: 6 psi, drying gas flow rate:5 L/min drying 
gas temperature: 250 ◦C.;                                                                                           
sheath liquid: 70% MeOH 10 mM NH4OAc at 7  μL/min. 
nebulizer pressure: 5 psi, drying gas flow rate: 5 L/min,  drying 
gas temperature: 200 
o
C.;        sheath liquid: 80% MeOH with 1 
mM NH4COOH at 5 μL/min.  nebulizer pressure: 5 psi, drying 
gas flow rate: 5 L/min, drying gas temperature:200 
o
C. 
 fritless packed 
column  24 
6,7-dihydroxy-1-methy-
TIQ, 1-benzyl-TIQ, and N-
methylsalsolinol  
sulfated β-
cyclodextrin 
20 mM acetic 
acid/ammonium acetate, pH 
5.5 
sheath liquid: 50% MeOH in H2O containing 0.1% acetic acid at 
2μL /min; spray voltage: 4 kV; capillary temperature: 220°C; 
sheath gas: 20 au; 
auxiliary gas:  0 au. 
fused-silica 
capillary 32 
12 cathinone analogs 
highly sulfated-γ-
cyclodextrin  50 mM phosphate,  pH 2.5  
source temperature: 250°C, drying gas: 5 mL/min, nebulizer 
pressure:10 psi, capillary: 3000 V, fragmentor: 125 V, skimmer: 
40 V. 
fused-silica 
capillary 33 
8 cathinone derivatives 
highly sulfated-γ-
cyclodextrin and (+)-
(18-crown-6)-
2,3,11,12-
tetracarboxylic acid  0.5% formic acid 
Electrospray voltage: 1.2 kV, the heated capillary of the mass 
spectrometer: 150 °C. 
fused-silica 
capillary 34 
 
8 amphetamine-type 
stimulants 
highly sulfated-γ-
cyclodextrin  10 mM HCOOH, pH 2.5  
 
coaxial sheath liquid: 10 mM ammonium formate–methanol 
(50:50, v/v) at 5 µL/min,  ESI voltage: 4.5 kV; nebulizer gas: 
5.0 au; ion transfer capillary temperature : 200 
o
C ; voltage: 17 
V. 
sulfonated 
capillary  35 
mephobarbital, 
pentobarbital, secobarbital poly-L-SUCIL 25.0 mM NH4OAc, pH 7.0 
Sheath liquid: 5.0 mM NH4OAc in MeOH/H2O 80:20 (v:v), 5 
μL/min. NP:  5 psi, DGF 4.0 mL/min, DGT 310°C. 
fused-silica 
capillary 40 
Hydrobenzoin, benzoin,  
benzoin methyl ether, and 
benzoin ethyl ether  
15% poly-L-SUCL 
and 85% of poly-L,L-
SULV 40 mM NH4OAc, pH 10 
Sheath liquid: 50% MeOH, 5 mM NH4OAc ,0.5% acetone at  10 
µL/min, DGF: 5.0 L/min, DGT: 100
o
C, VT: 176 
o
C. 
fused-silica 
capillary 44 
ephedrine, 
pseudoephedrine, 
norephedrine, 
methylephedrine, atenolol, 
metoprolol, talinolol, 
carteolol 
undecylenic α-D-
glucopyranoside 4,6-
hydrogen phosphate, 
sodium Salt 
25.0 mM NH4OAc, pH 7.0 
and 5.0 
Sheath liquid: 5.0 mM NH4OAc in MeOH/H2O 
80:20 (v:v), 5 μL/min. NP: 3 psi, DGF 6.0 mL/min, DGT 
200°C. 
fused-silica 
capillary 45 
30 neutral and basic chiral 
compounds and two acidic 
compounds 
glycidyl 
methacrylate-bonded 
β-cyclodextrin  
variable ACN 
concentration was combined 
with  5mM NH4OAc 
containing 0.3% (v/v) TEA 
sheath liquid, MeOH/H2O (80:20, v/v) containing 5 mM 
NH4OAc,at 5.0 μL/min; capillary voltage, +2000 V; drying gas 
flow rate, 5 L/min; drying gas temperature, 200 °C; nebulizer 
pressure, 5 psi. monolithic column  51 
acidic compounds(2-
Phenoxypropionic 
Acid,2,2-(Chlorophenoxy) 
propionic acid; BNP etc. 
The GMA/β-CD-
VBTA 
75/25 ACN/H2O, 5 mM 
NH4COOH, pH 3.0 
drying gas temperature, 150 °C; drying gas flow rate, 3 L/min; 
nebulizer pressure, 20 psi; capillary voltage, −3500 V; 
fragmentor voltage, 84 V monolithic column  52 
ephedrine and 
pseudoephedrine 
poly-SAAOCL, poly- 
SAADCL and poly-
SAADoCL 
70% (v/v) ACN and 30% 
(v/v) aqueous buffer 
containing 5 mM NH4OAc, 
pH 5.0. 
nebulizer pressure, 7 psi; drying gas flow rate, 5 L/min; drying 
gas temperature, 150 °C; capillary voltage, 3500 V; fragmentor, 
90 V. Sheath liquid: 80/20 MeOH/H2O (v/v), 5 mM NH4OAc 
(pH 6.8) , 8 μL/min. monolithic column  53 
3,4-
dihydroxyphenylalanineand 
its precursors, 
phenylalanine and tyrosine sulfated β-CD 
0.2 M 
formic acid 
sheath liquid, 50% MeOH in water containing 0.1% formic acid 
at 3 μL/min; spray voltage, 4 kV; capillary temperature, 220  oC; 
sheath gas, 20 au; auxiliary gas, 0 au. 
fused-silica 
capillary 54 
 
venlafaxine and O-
desmethylvenlafaxine poly-L,L-SULA 
20 mM NH4OAc + 25 mM 
TEA, pH8.5 
sheath liquid: 80/20 MeOH/H2O (%v/v) containing 5 mM 
NH4OAc at 5  μL/min, Capillary voltage, +3000 V. drying gas 
flow rate: 8.0 L/min; drying gas temperature: 200 
o
C; nebulizer 
pressure: 3 psi. 
fused-silica 
capillary 55 
Table 1.1  Recent applications of chiral CE-MS from2010 to 2015 
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1.3.1 Charged Cyclodextrins (CD) in CEKC-MS 
Charged CDs are the most commonly used chiral selector in CEKC-MS applications. 
This class of chiral reagent is predominantly used in drug development, quality control, 
pharmacokinetic and pharmacodynamic studies owing to their remarkable enantiorecognition 
capability, special physicochemical properties and ease of commercial availability [25-29].  As 
mentioned earlier in section 2.2, charged CDs or their derivatives when added to the BGEs work 
as a PSP for the enantioseparation in EKC-MS buffers.   However, introduction of even small 
amount of this class of nonvolatile chiral selector was reported to cause serious contamination of 
the ion source [30] resulting in the suppression of MS analyte signal [31]. Therefore, two 
different approaches such as counter-current migration (i.e., chiral selector migrating opposite to 
EOF) and partial filling technique (PFT) have been employed in CEKC-MS to minimize the 
contamination of the electrospray chamber with CDs.  Both of these two approaches have shown 
to improve the sensitivity and the stability of the ESI-MS signal but the later technique decreases 
the enantioselectivity.  
Wu et al. [32] developed a partial-filling CEKC-MS/MS method to separate and detect 
the enantiomers of tetrahydroisoquinoline derived neurotoxins including (R/S)-6,7-dihydroxy-1-
methy-TIQ (salsolinol, Sal), (R/S)-1-benzyl-TIQ (BTIQ), and (R/S)-N-methylsalsolinol (NMSal). 
Only 1.0mM sulfated β-CD was used as chiral selector and added to the BGE of 20 mM acetic 
acid/ammonium acetate at pH 5.5 to provide the 1,2,3,4-tetrahydroisoquinoline derivatives with 
chiral Rs ranging from 3 to 4.5.  The resolutions reported by EKC -MS were much higher than 
those reported previously by HPLC methods.  Moreover, the LOD of this method was only as 
low as 1.2µM for Sal enantiomers.  The developed assay was successfully applied to study in 
vitro formation of NMSal, a Parkinsonian neurotoxin.  The four isomers of  NMSal were 
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separated, detected in the incubation solution and were identified as (R)-e.e-NMSal, (R)-e.a-
NMSal, (S)-e.e-NMSal, and (S)-e.a-NMSal.  The authors claimed this to be the first study 
identifying the multiple enantiomeric form of NMSal.    
Recently, PFT have been effectively used in CEKC-MS especially in seized drug analysis 
[33]. Using 0.6% v/v highly sulfated-γ-cyclodextrin (HS-γ-CD) at pH 2.5 , 9 out of 12 cathinone 
analogs were enantioseparated and detected with TOF-MS.  The authors reported that the use of 
PFT not only successfully prevented the nonvolatile portion of the buffer from entering the MS 
but also greatly reduced the baseline noise on the MS by 45%. Initially, the separation 
parameters such as buffer pH and concentration of the chiral selector were optimized in UV 
detection before applying to the MS detection but the use of length of the chiral selector was 
optimized with CE-MS. The limit of detection as low as 1.2 ng/mL was reported for cathinone 
analog [(±) ethcathinone].  The method was validated in terms of linearity, sensitivity and limit 
of quantitation and was applied to the identification of methylone in seized drug samples.  
In a very recent study [34], enhanced resolution was observed when 0.125 % HS-γ-CD 
and 15 mM(+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid (18-C-6-TCA) was investigated 
using an online sheathless CE/MS with low flow rates of nanoliters/minute to separate and detect 
eight cathinones along with their positional and optical isomers. The authors took advantage of 
the separation capability of both HS-γ-CD and (+)-18-C-6-TCA to achieve the baseline 
enatioseparations of all cathinones derivatives except for (±)-4-methylethcathinone, which was 
partially resolved. In addition, the low flow rate (~10 nL/min) sheathless CE/MS was compared 
with PFT for the enantioseparations of cathinones derivatives. It was found that the relative and 
absolute sensitivity of detection of cathinones were almost the same in both techniques, 
indicating that the low flow rates CE-MS system using a sheathless interface in conjunction with 
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a narrow capillary (20 μm i.d.) provides no significant suppression when HS-γ-CD was 
introduced into the ESI process. 
Besides PFT and sheathless CE/MS with low flow rates, chemically modified capillary 
can also be used to prevent the MS ion source contamination [35].  Mikuma and coworkers 
recently reported an EKC-MS/MS method for 8 amphetamine-type stimulants using sulfonated 
capillary and HS-γ-CD as chiral selector in 10 mM formic acid at pH 2.5 in EKC-MS/MS.  Fig. 
1.4 shows the extracted ion electropherograms for simultaneous chiral separations of 8 
amphetamine-type stimulants.  Baseline separations were achieved for all enantiomers within 60 
min. When chemically modified sulfonated capillary is used, the chiral selector, HS-γ-CD 
countermigrates to the detector and avoided migration towards the ion source.  In addition, such 
modified capillary also improves the repeatability of migration times with % RSD of intraday 
and interday to be not higher than 0.3% and 1.02 %, respectively.  Although these results are 
excellent but a rather low number of runs were performed to truly evaluated the feasibility of run 
time repeatability. 
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Fig.1.4 Extracted ion electropherograms obtained from the mixture of the 8 ATS (50 mg/mL for 
individual enantiomers). Taken from ref [35] with permission. 
 
 
1.3.2 Molecular micelles in CMEKC-MS 
 Identifying novel chiral selectors providing high separation selectivity and are MS 
compatible has become a major effort in developing sensitive MEKC-MS approaches.  High 
molecular mass polymeric chiral surfactants [aka. molecular micelles (MoM)] are usually 
beneficial for MEKC-MS because of three major advantages.   First, MoMs are covalently 
stabilized high molecular weight micellar aggregates, which cannot be fragmented in the gas 
phase of ESI-MS resulting in no interference with the analyte signals. Second, MoMs are stable 
over a wide range of pH and are fully compatible with the use of water soluble organic solvents. 
Third, because of zero critical micellar concentration (CMC), very low concentration of MoMs 
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can be used without sacrificing the chiral Rs [36-38]. In recent years, there has been rapid growth 
in the development of CMEKC-MS using MoMs [39-43]. 
Until now, the potential applications of MEKC-MS for chiral analysis has been 
established mainly for the simultaneous separation and identification of various chiral 
pharmaceuticals and its metabolites (i.e., chiromics), interfacing to other ionization sources, 
search for new classes of MS compatible chiral MoMs  and studies involving drug-drug 
interactions.   
 Wang and co-workers [40] developed a CMEKC-MS approach using poly sodium N-
undecenoxy carbonyl-L-isoleucinate (poly-L-SUCIL) as a chiral selector to simultaneously 
separate and detect the enantiomers of three barbiturates in 32 min.  A careful screening of 
various polymeric chiral surfactants was first performed to select the best chiral selector. Next, 
separation parameters such as chiral Rs, total analysis time and S/N ratio were optimized by 
multivariate central composite design (CCD) to obtain the highest overall chiral Rs and S/N ratio 
under the shortest possible run times.  The optimum MEKC-MS conditions were tested by a 
series of experimental runs and it was found that the results were in good agreement with the 
predicted results. Finally, the optimized MEKC-MS method was applied to the analysis of 
barbiturates in human serum samples. 
When the chiral analytes are highly non-polar or neutral in solution, they can only be 
separated using a charge chiral MoM but still could be ionized in the gas phase as charged 
species by atmospheric pressure photoionization (APPI-MS).   In a recent report, CMEKC was 
coupled to APPI-MS for the first time for analysis of four benzoin derivatives [i.e., hydrobenzoin 
(HBNZ), benzoin (BNZ), benzoin methyl ether (BME) and benzoin ethyl ether (BEE)] [44].  
Before carrying out the separation experiments, direct infusion APPI-MS experiments for the 
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four benzoin derivatives in both positive and negative ion modes were conducted to determine 
the fragmentation pathway.  In positive ion mode, the protonated molecular ion of benzoin 
derivatives were not found to be the most abundant fragment ions. Instead [M+H-H2O]
+, [M+H-
CH3OH]
+and [M+H-C2H5OH]
+ were observed as most abundant species for BNZ /HBNZ as well 
as benzoin methyl ether and benzoin ethyl ether, respectively (Fig.1.5).  The inserted bar plots in 
Fig. 1.5 shows that the addition of acetone as dopant increases the sensitivity of BNZ and HBNZ 
but not for BME and BEE.  The trends clearly suggested that the proton affinity for BNZ and 
HBNZ is greater than that of the solvent (methanol) as well as the dopant (acetone).  Therefore, 
proton transfer reaction was possible through formation of solvent clusters.   
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Fig.1.5 APPI-MS spectra of the four BNZ compounds. The inset plots of HBNZ and BNZ show 
the signal intensity with and without 0.5% acetone. The error bar in each plot represents 3(σ) 
standard deviations. Taken from ref [44] with permission. 
 
 
 
Using a binary mixture of two MoMs  [poly sodiumN-undecenoxy carbonyl-L-leucinate 
(poly-L-SUCL) and poly sodium N-undecenoyl-L,L-leucylvalinate (poly-L,L-SULV)] 
simultaneous enantioseparation and APPI-MS detection of all four neutral benzoins were 
achieved.  Next, the MEKC parameters such as total surfactant concentration, voltage, buffer pH 
and etc. were optimized to obtain highest Rs/tR using multivariate central composite design 
(CCD) and the models were validated by ANOVA. Similarly, the sheath liquid composition 
(methanol composition, dopant concentration and flow rate) and spray chamber parameters 
(drying gas flow rate, drying gas temperature and vaporizer temperature) were also optimized by 
CCD to achieve the maximum value of MS sensitivity (measure as peak area). Under the overall 
optimum multivariate conditions the MEKC-APPI-MS for the four benzoin derivatives was 
compared to MEKC-UV (Fig. 1.6).  The comparison suggested that MEKC-APPI-MS offered 
much higher sensitivities up to 11 times higher than MEKC-UV for benzoin derivatives.  
Overall, higher Rs were obtained in MEKC-APPI-MS but at the cost of longer retention time. 
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Fig.1.6 Representative electropherograms showing the comparison of CMEKC-UV versus 
CMEKC-APPI-MS. Experimental conditions: 120 cm 50 μm id fused-silica capillary; 55Mm 
NH4OAc, pH 8.0, with 50mM poly-L,LSULV, 15mM poly-L-SUCL; 1 25 kV, 201C; analyte: 
1mg/mL BNZ derivatives in 50/50MeOH/H2O, injected at 5mbar, 10 s; spray chamber 
parameters: DGF 5 L/min; nebulizer pressure 5 psi; DGT 150oC; VT 150oC; capillary voltage 
2000 V; fragmentor 80 V, gain 3; SIM at m/z = 195,197; UV absorbance at 214 nm; sheath 
liquid: 5mM NH4OAc in 50/50 MeOH/H2O, 0.5% Acetone; flow rate 7.5 mL/min. Taken from 
ref [44] with permission. 
 
Very recently, a novel polymeric glucose based surfactant such as n-alkyl-α-D-
glucopyranoside surfactants for enantioseparation of various chiral pharmaceuticals in MEKC-
MS/MS was evaluated. [45] The polymerization conditions for the formation of MoMs of n-
undecenyl α-D-glucopyranoside 4,6-hydrogen phosphate, sodium salt was first characterized by 
varying the polymerization concentration and profiling the chiral resolution of one anionic and 
one cationic compound. Next, the influence of polymeric glucopyranoside-based surfactants 
head groups and carbon chain length were optimized over a wide range of pH for chiral 
resolution of ephedrine alkaloids and β-blockers.  The studies indicated that enantioseparations 
of ephedrine alkaloids and β-blockers could be achieved at optimum pH 5.0 and 7.0, respectively 
using ammonium acetate buffer, 25 mM polymeric n-undecyl α-D-glucopyranoside 4,6-
hydrogen phosphate, sodium salt.  The LODs were as low as 10 ng/mL and 50 ng/mL for 
enantiomers of ephedrines and β-blockers, respectively. 
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1.3.3 Stationary phases in CCEC-MS 
 Historically, three main types of chiral stationary phase are commonly used in CEC: 
column packed with particles, monolithic columns and open tubular (OT) capillary columns.  
Chiral stationary phases used in HPLC have been successfully transferred to packed column and 
OT- CEC–MS.   However, in the last five years no application was reported for OT-CEC-MS.  
Perhaps, this could be attributed to low sample capacity of OT columns.  On the other hand, 
there have been publications on the development of fritless packed columns and monolithic 
columns for CCEC-MS applications. 
 The traditional approach for packing particle based chiral stationary phase in packed 
columns for CEC-UV requires two frits to hold the packing material.  Unfortunately, this method 
presents many drawbacks for CEC-MS.  First, irreproducible retention times and frequent current 
breakdown occurs due to extensive bubble formation at the outlet end exposed to the sprayer end 
of the MS instrument.  Second, the frit formation itself is prone to changes in EOF due to 
difference in physical and chemical nature of the sintered frit.  Although better performance were 
achieved using single frit internal tapered columns [46-49], the possibility of  bubble formation 
caused by the inlet frit still remains exclusive problem  for external tapered columns.  
 The development of fritless column for chiral CEC-MS was first reported in 2011 by 
Bragg and Shamsi [24].  The fritless packed column for CEC-MS was fabricated by using two 
internally tapered packed columns joined together by a commercially available New Objective 
PicoClear connector (Fig.1.7). The design of fritless column overcomes the drawbacks of 
traditional two fritted capillary columns while maintaining the benefits of broader compatibility 
with a variety of chiral packing materials and easy conditioning protocols in the CE-MS 
instrument. To test the robustness of fritless column, 90 consecutive runs were performed for 
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chiral separation of (+/-) aminoglutethimide with intraday and interday % RSD in the range of 
3.2-3.7.  Furthermore, the chiral CEC-MS, fritless column was reported to have better efficiency 
with equally good sensitivity and chiral resolution as single column packed with the same chiral 
stationary phase. In addition, the fritless column proved its compatibility with a variety of 
commercially available packing material for achiral separations with very good column-to-
column and operator-to-operator reproducibility. 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.7 Schematic of fritless column with the New Objective PicoClear connector. The 
elastomeric insert of the connector ensures that the two capillaries do not grind together when 
joined. The arrows, at the bottom, represent the lengths of the inlet packed portion (15 cm) and 
outlet packed portion (35 cm) of the fritless column (not to scale). Taken from ref [50] with 
permission. 
 
 Although many of the problems associated with particle based packed chiral stationary 
phase in CEC are resolved today, the longer run times obtained in CEC-MS still remains  the 
bottleneck for analysis of chiral compounds.  Recently, only seven cm long single frit column 
packed with cellulose based chiral stationary phases was reported to provide high throughput 
analysis of chiral compounds in CEC-MS [24].   Bragg and Shamsi compared the performance of 
the two cellulose-based packed columns, cellulose tris (3,5-dimethyl-phenyl-carbamate) 
(CDMPC) and sulfonated cellulose tris (3,5-dimethylphenylcarbamate) (CDMPC-SO3) CSP for 
rapid enantioseparation in CEC-MS.   The column packed with the charged chiral stationary 
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phase such as  CDMPC-SO3CSP provided much faster analysis time with baseline Rs when 
compared to the neutral chiral stationary such as CDMPC for  the enantioseparation of 
glutethimide, aminoglutethimide, warfarin and 2,2,2-trifluoro-1-(9-anthryl) ethanol.  Therefore, 
this promising research has opened the possibility of packing short chiral columns to perform 
high throughput screening in CEC-MS. 
1.3.3.2 Monolithic column in CCEC-MS 
Because the use of monolithic columns provides all the benefits of tapered packed 
columns and is less prone to bubble formation, a recent trend is the development of monolithic 
chiral columns for CEC-MS.   Chiral monoliths developed for CEC-MS requires no end frits and 
the polymer forms a single continuous rod of porous material. In contrast to particle based 
column, the chiral monolithic columns have abundance of mesopores.   
 Recently, the use of methacryloyl-bonded β-CD to prepare monolithic column in few 
hours has attracted interests [50].  In this work, the author reported a versatile chiral monolithic 
column prepared by polymerization of glycidyl methacrylate-bonded β-cyclodextrin (GMA-β-
CD) with ethylene dimethacrylate (EDMA), in the presence of commonly used porogens and a 
negatively charged achiral monomer.   This GMA-β-CD-AMPS monolithic column was applied 
for CCEC-MS for the first time.  While at least 30 compounds were enantioresolved by CEC-
UV, in case of CEC-MS chiral separation of five positively charged chiral compounds and two 
acidic compounds was reported as summarized in Table 1.2.   Although the preparation of 
monolithic column for CEC-MS was not fully optimized, a general comparison of CEC-UV with 
CEC-MS showed higher S/N ratio but slightly lower chiral Rs with the later. The presence of an 
empty segment of 20 cm at the inlet end of the CEC-MS column might have contributed to some 
band broadening and Rs loss in CEC-MS.  However, the effective length of the monolithic bed in 
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CEC-UV was the same as in CEC-MS. Nevertheless, the monolithic column demonstrated 
excellent stability and reproducibility of retention times and enantioresolution using hexobarbital 
as the model chiral analyte.   
 
Table 1.2  Chiral separations of five positively charged compounds and two negatively charged 
compounds using GMA-β-CD-AMPS monolithic column in CEC-MS. Taken from ref [50] with 
permission. 
 
 
 
 
 
 
 
 
 
 
 
The same strategy was employed by polymerization of glycidyl GMA-β-CD with EDMA 
and porogens but in the presence of positively charged achiral monomer [(vinylbenzyltrimethyl 
ammonium chloride, VBTA] [51].  The use of VBTA monomer provided abundance of anion 
exchange sites with reversed EOF.  In contrast to GMA-β-CD-AMPS, the use of GMA-β-CD-
VBTA column separated significantly more acidic compounds. (Table 1.3) Furthermore, the 
GMA-β-CD-VBTA monolithic column provided two orders of magnitude higher sensitivity 
when coupled to triple quadrupole mass spectrometer compared to single quadrupole mass 
Analytes Rs α S/N 
hexobarbital  1.61 1.04 177 
catechin 1 1.03 118 
flavanone 0.86 1.03 80 
pseudoephedrine 2.53 1.14 320 
Troger's Base 1.39 1.07 115 
aminoglutethimide 1.51 1.05 75 
prilocaine 1.34 1.07 520 
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spectrometer for several chiral compounds.   Further studies are warranted to fully explore the 
potential of this β-CD based chiral monolithic column with a variety of charged monomers and 
crosslinkers for CEC-MS. 
 
Table 1.3 Chiral separation of acidic and basic compounds using GMA-β-CD-VBTA monolithic 
column in CEC-MS. Taken from ref [51] with permission. 
 
Chiral Compounds Rs 
2-Phenoxypropionic acid  1.5 
2,3-(Chlorophenoxy)propionic acid  1.5 
2,4-(Chlorophenoxy)propionic acid  1.3 
2,2,4-(Dichlorophenoxy)propionic acid 0.5 
2,2,4,5-(Trichlorophenoxy)propionic acid 0.5 
2-Phenylbutyric acid 1.2 
DNS-Valine 2 
DNS-Leucine  1.3 
DNS-Threonine  2.9 
DNS-Serine 2.2 
2,4-DNP-Methionine sulfone  1.1 
2,4-DNP-Norleucine  0.9 
2,4-DNP-Norvaline 2.4 
2,4-DNP-Threonine  2.4 
3,5-(Dinitrobenzoyl)phenylglycine 0.5 
3,5-(Dinitrobenzoyl)leucine  1.5 
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Mandelic acid  0.1 
Acetylmandelic acid  0.5 
Atrolactic acid 2.1 
4-Chloromandelic acid  1 
3,4-(Methylenedioxy)mandelic acid 1.1 
α-Bromophenyl acetic acid  0.8 
α-Methoxyphenyl acetic acid  1.3 
Ibuprofen  0.5 
Warfarin 1.4 
Coumachlor 1.4 
BNP  0.5 
 
 
Besides the CDs, other popular chiral selectors such as chiral surfactants have been used 
to prepare CSPs for chiral monolithic CEC.  Shamsi’s group developed a novel amino-acid 
surfactant bound chiral polymeric monolith [52].  In this latest study, chiral separations were 
realized in CEC and CEC-MS using surfactant bound chiral polymeric monolith derived from an 
acryloylamide tail, a carbamate linker, and an amino acid head group. When preparing the 
monolithic phase, the composition of polymerization mixture including the acid form of the 
chiral surfactant monomer, porogen, cross-linker was optimized to yield the best monolithic 
CSPs for CEC. Compared to the use of β-CD based chiral monolithic column, the surfactant 
based monolithic column was found to be superior (Fig.1.8) in terms of simultaneously resolving 
structurally similar analytes (EP and PEP).  Three surfactant-bound monolithic columns prepared 
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by polymerizing leucine-based carbamate chiral surfactants with different alkyl chain length 
[namely, sodium 8-acrylamidooctenoxy carbonyl-L-leucinate (SAAOCL), sodium 10-acryl-
amidodecenoxy carbonyl-L-leucinate(SAADCL), and sodium 12-acryl-amidododecenoxy 
carbonyl-L-leucinate (SAADoCL)] were successfully synthesized and characterized. The 
enantiomers of (±)PEP was used as a model chiral cationic analyte to investigate the effect of the 
mobile phase parameters on the retention factors. Under the optimized conditions, SAADCL 
monolithic column simultaneous separated EP and PEP isomers by CCEC-MS/MS with a run 
time of 44 min  (Fig.1.9).   Although the electrospray parameters were not extensively optimized, 
higher S/N ratio observed in MRM mode suggests LOD in low ng/mL range.  To decrease the 
analysis time for CEC-MS, it is important to screen various surfactant head groups, and a range 
of crosslinkers to test the compatibility of this surfactant-bound monolith column in the CEC-
MS/MS mode.  
 
 
 
 
 
 
 
 
 
 
Fig. 1.8 Comparison between poly-(GMA-β-CD-co-EDMA-co-AMPS) column (A) and poly- 
(AADCL-co-EDMA) column (B) for simultaneous enantioseparation of (±)-PEP and (±)-EP 
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enantiomers. The CEC column dimensions for the poly(GMA-β-CD-co-EDMA-co-AMPS) 
columns are the same as described in Figure 1.1. Mobile phase: 50%(v/v) ACN and 50% 
aqueous buffer, 5 mM NH4OAc, 0.3% (v/v) TEA (pH 4.0). Mobile phase conditions for the 
AADCL column are the same as described in Figure 1.3. Both (±)-PEP and (±)-EP (1 mg/mL) 
are dissolved in 50/50 ACN/H2O (v/v); injection, 5 kV for 3 s. Taken from ref [52] with 
permission. 
 
 
 
 
 
 
 
 
 
Fig.1.9 CEC−ESI-MS/MS of (±) PEP and (±) EP with AADCL column. CEC conditions: 53 
cmlong column, 30 cm monolithic bed length. 0.3 kV/cm (15 kV); high pressure, 5 bar applied at 
inlet end of the column. Other conditions are the same as in Figure 1.1 The (±) PEP and (±) EP 
(50 μg/mL) were injected at 5 kV for 3 s. The MRM product ions were observed at m/z 115.1 
and 133.1 for (±) PEP and m/z (±) EP respectively; nebulizer pressure, 7 psi; drying gas flow 
rate, 5 L/min; drying gas temperature, 150 °C; capillary voltage, 3500 V; fragmentor, 90 V. 
Sheath liquid: 80/20 MeOH/H2O (v/v), 5 mM NH4OAc (pH 6.8) delivered at a flow rate of 8 
μL/min. Taken from ref [52] with permission. 
 
1.4 Biomedical and clinical applications  
Chiral CE-MS is slowly establishing as an efficient tool for drugs and metabolites 
analysis in biological matrices due to its high efficiency, high chiral selectivity, and high 
sensitivity.   Though biological samples analyzed by chiral CE-MS are not as routinely used as in 
HPLC-MS, yet CE-MS has distinguished advantages over HPLC-MS for drug analysis in 
biological samples.  For example, HPLC-MS requires expensive special chiral column while CE-
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MS only needs few mg of exotic chiral selector, which is either added to the background 
electrolyte in EKC-MS or MEKC-MS or attached to the capillary wall in CEC-MS.  In addition, 
CE-MS consumes much less sample volume especially when sample size for biological analysis 
is very limited.  
Liu’s et al. developed a chiral PFT EKC-MS/MS method for enantiomeric quantification 
of 3,4-dihydroxyphenylalanine (DOPA), phenylalanine and tyrosine using sulfated β-CD as 
chiral selector in less than 12 min [53].  This assay was successfully applied to study the 
metabolism of DOPA in PC-12 nerve cells.   Prior to the metabolic study in chiral CE-MS, PC-
12 cells were cultured in complete RPMI medium under 10% heat-inactivated horse serum and 
5% fetal bovine serum for 4-5 days.  The racemic or enantiomerically pure form of DOPA was 
then added at a concentration of 500 µM and was incubated with 5-mL of PC-12 cell suspension 
(2 x 106 cells/mL) for 2 hrs at 37 oC. After incubation, cells were removed by centrifugation and 
the proteins were removed by precipitation with trichloroacetic acid.   
Fig. 1.10 (A-C) shows the metabolic profiles of D- and L-DOPA.  In Fig.10A, the two 
enantiomers of DOPA standard solution were separated before 11 min. Fig. 10B and C show the 
enantioseparation of DOPA incubated with the culture medium and with PC-12 cells, 
respectively. Interestingly, the peak areas of L-DOPA from incubation with PC-12 cells 
decreased greatly suggesting that L-DOPA was metabolized effectively, whereas D-DOPA was 
not metabolized.  Thus, EKC-MS/MS analysis demonstrated the enantioselective metabolism of 
DOPA in vitro neuron model for the first time. 
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Fig.1.10 Electropherograms obtained from studying DOPA metabolism: (A) racemic DOPA 
standard solution (50 μM for each enantiomer); (B) 500 μM racemic DOPA incubated with the 
culture medium for 2 h; (C) 500 μM racemic DOPA incubated with PC-12 cells (2×106 cells/ml) 
for 2 h. Chiral CE–MS/MS condition were as follows: sheath liquid, 50% methanol in water 
containing 0.1% formic acid at 3 μl/min; ESI spray voltage, +4 kV; capillary temperature, 220 
oC; sheath gas, 20 au; auxiliary gas, 0 au. Taken from ref [53] with permission. 
 
 
When chiral CE-MS is applied in body fluid such as plasma or serum, sample preparation 
is required prior to the analysis. For example, solid phase extraction (SPE) and liquid-liquid 
extraction (LLE) are the most commonly used sample preparation techniques. More recently, 
polymeric dipeptide MoM, N-undecenoyl-L,L-leucylvalinate (poly-L,L-SULV) was successfully 
utilized as PSP in CMEKC-MS/MS for the simultaneous separation of warfarin and its five 
hydroxyl warfarin metabolites in one single run [38]. The simultaneous enantioseparation were 
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realized using 25 mM poly-L,L-SULV added to the BGE, 25 mM NH4OAc at pH 5.0.   Next, the 
authors compared the separation in MEKC-MS with CEC-MS using vancomycin as a packing 
material and found that CMEKC-MS was superior to CCEC-MS. As shown in Fig. 1.11, the 
comparison clearly showed that the total analysis time of packed column CEC-MS is 100 min 
while MEKC-MS offered much shorter analysis time of less than 40 min, though chiral 
resolution of warfarin and its metabolites were achieved in both CE-MS modes. To increase the 
detection sensitivity for application in biological samples, CMEKC-MS/MS was investigated.  
Fig.12 shows the comparison of the detection of warfarin and its hydroxylated metabolites by 
MEKC–MS and MEKC-MS/MS and it was found that triple quadrupole MS provided much 
higher S/N than single quadrupole MS. Finally, the CMEKC-MS/MS method was applied to 
analyze the patients serum samples with LOD at 2 ng/mL and limits of quantitation (LOQ) at 5 
ng/mL. 
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Fig.1.11 Optimized enantioseparation of WAR and its hydroxylated metabolites by CEC–ESI-
MS (A–D). Conditions: 40 cm long vancomycin packed column (total long 65 cm, 375 μm O.D. 
and 75 μm I.D.). Running buffer, ACN/H2O (45/55, v/v), 10 mM NH4OAc at pH 4.0 (A) and 
ACN/MeOH/H2O (30/50/20, v/v/v), 10 mM NH4OAc at pH 4.0 (B). Applied voltage, +25 kV; 
injection, 5 kV, 3 s. Spray chamber and sheath liquid conditions nebulizer pressure: 4 psi, drying 
gas temp.: 200 oC, drying gas flow: 6 L/min, capillary voltage: −3000 V, fragmentor voltage, 91 
V, SIM mode; sheath liquid: MeOH/H2O (80/20, v/v), 5 mM NH4OAc, pH 6.8 with flow rate of 
0.5 μL/min; and sample concentration: 10 μg/mL in ACN/H2O (40/60, v/v). Taken from ref [38] 
with permission. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.12 Comparison of the detection of WAR and its hydroxylated metabolites by MEKC–MS 
(A and C) and MEKC–MS/MS (B and D). For MEKC–MS, all the conditions are the same as in 
Fig. 1.11. MEKC–MS/MS conditions: 120 cm long (375 μm O.D. and 50 μm I.D.) fused silica 
capillary. Buffer: 25 mM NH4OAc pH 5.0, 25 mM poly-l,l-SULV with 15% (v/v) MeOH; 
injection: 5 mbar for 2 s; voltage: 30 kV; spray chamber parameters: drying gas temperature: 200 
oC, drying gas flow rate: 8 L/min, nebulizer pressure: 4 psi, capillary voltage: −3000 V, collision 
energy: 20 eV for all except 5 eV for I.S., fragmentor voltage: 125 V for all except 75 V for I.S. 
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Sheath liquid: MeOH/H2O (80/20, v/v) with 5 mM NH4OAc, sheath liquid flow rate: 5 μL/min. 
Taken from ref [38] with permission. 
 
 
Besides the work we discussed in section 1.3.2 [38], there is one latest publication on 
CMEKC-MS/MS application for the simultaneous analysis of anti-depressant drug, venlafaxine 
(VX) and its structurally-similar major metabolite, O-desmethylvenlafaxine (O-DVX) in human 
plasma samples [54].  The MoM, poly-sodium N-undecenoyl-L,L-leucylalaninate (poly-L,L-
SULA) was employed as the chiral selector after screening several dipeptide surfactants.  
Baseline enantio-separation of both O-DVX and VX enantiomers was achieved in ~15 min after 
optimizing the pH, poly-L,L-SULA concentration, nebulizer pressure and voltage. Calibration 
curves in spiked plasma (recoveries higher than 80%) were linear.  The LODs were found to be 
as low as 30 ng/mL and 21 ng/mL for O-DVX and VX, respectively.   
The CMEKC-MS method was implemented in a case study involving the plasma 
concentrations of human subjects receiving VX or O-DVX orally when co-administered without 
and with indinivar (used in HIV therapy).  A series of electrochromatograms are compared in 
Fig. 1.13.  When one particular human subject is treated without indinavir therapy, the S/R ratio 
of peak height of O-DVX slightly increases from 0.83 to 0.98 after drug is administered at 1 hr 
and 4 hrs, respectively (left column).  In contrast, note that significant decrease in peak height 
ratio of S/R enantiomers of O-DVX is observed in the subject with indinavir therapy at 4 hrs 
compared to 1 hr.  Further data in this studies suggested that MEKC-ESI-MS/MS is an effective 
alternative approach for the pharmacokinetic and pharmacodynamic studies of both O-DVX and 
VX enantiomers. Thus, potential drug-drug interactions involving VX and O-DVX enantiomers 
with indinavir could be identified.  
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Fig.1.13 Total ion electrochromatograms of subject treated with O-DVX without and with 
indinavir therapy at 1 h and 4 h, respectively. The MEKC–MS/MS conditions: 60 cm long (375 
μmO.D., 50 μm I.D.) fused silica capillary. Buffer: 20 mM NH4OAc + 25 mM TEA, pH 8.5, 15 
mM polydipeptide surfactant. Applied voltage, +25 kV, injection, 5 mbar,100 s. Spray chamber 
parameters: nebulizer pressure: 3 psi, drying gas temp.: 200◦C, drying gas flow: 8 L/min; 
capillary voltage: +3000 V; fragmentor voltage,113 V for O-DVX and 117 V for VX; collision 
energy: 17 eV; MRM transition: O-DVX: 264.2 → 58.1; VX: 278.2 → 58.1. Sheath liquid: 
MeOH/H2O (80/20, v/v), 5 mMNH4OAc, pH 6.8 with flow rate of 0.5 mL/min; The MRM 
precursor to product ion transition for R-atenolol is 267.2 → 145.2. The enantiomer S-O-DVX 
eluted first followed by the R-O-DVX. (1,1'= O-DVX). Without indinavir therapy: S/N1= 118, 
S/N1'= 171 at 1 h and S/N1= 199, S/N1'= 210 at 4 h. With indinavir therapy: S/N1= 207, S/N1'= 
210 at 1 h and S/N1= 367, S/N1'= 630 at 4 h for S- and R-enantiomer of O-DVX, respectively. 
Taken from ref [54] with permission. 
 
1.5. Conclusions and future prospects 
One of the major limitations of HPLC-MS is the careful selection of chiral stationary 
phase and/or MS compatible mobile phase combinations for the separation of chiral drugs and its 
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metabolites.  In addition, HPLC-MS is expensive, time consuming and resource consuming 
compared to CE-MS. High selectivity, high efficiency and low operation expense allows chiral 
CE-MS to be a powerful analytical method.  The contamination of the MS source by low 
molecular weight chiral selectors can be avoided by using; (a) charged CDs with PFT, (b) high 
molecular weight MoMs and (c) variety of low cost MS compatible chiral CEC columns.  
Therefore, CCEKC-MS, CMEKC-MS and CCEC-MS will continue to be advantageous for 
sensitive detection of enantiomers. 
Over the past five years, the demonstration of the applicability for chiral analysis studies 
has continued in various modes of CE-MS, as indicated by 22 publications of which the majority 
was directed in targeted analysis (Table 1.1).  A growing trend in chiromics is to use a 
combination of highly efficient chiral separations with highly sensitive MS detection. In 
addition, analysis of parent chiral drugs and its chiral metabolites in biological samples in a 
single run using a single method will be of great value in the future. In this regard, chiral CE-MS 
has demonstrated to be a highly useful complementary tool to HPLC-MS.  The chiral CE-MS 
based application studies discussed in the last section are mainly application driven, with the 
potential to develop into a robust clinical assay.  
To this date, CEKC-MS using a combination of charged CDs with PFT has great 
potential to be used in drug development and drug quality control, pharmacokinetic as well as 
pharmacodynamics studies due to the availability of commercially available chiral selectors.  
Furthermore, in the past few years, the application of CMEKC-MS using chiral MoMs is 
particularly shown to be advantageous for the analysis of biological samples. Because CMEKC-
MS mainly depends on the development of MS compatible chiral selectors, the commercial 
availability of MoM will foreseeably be of great significance.   
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To the best of our knowledge until now, various modes of chiral CE (EKC, MEKC and 
CEC)-MS have been carried out with a sheath flow interface.  Further studies in the development 
of new interfacing techniques, such as the sheathless porous tip [34], and the EOF driven sprayer 
using borosilicate glass combined with sheath flow  [55] has great promise to increase the 
sensitivity of chiral metabolites. Both of these interfaces are now commercially available.  In 
addition, the compatibility of chiral nanoparticles and surfactant bound polymeric monoliths is 
an area that remains essentially unexplored. 
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Chapter 2 
 
Synthesis, characterization and application of polymeric n-alkyl α-D-
glucopyranoside surfactants for enantioseparation in micellar electrokinetic 
chromatography-tandem mass spectrometry 
(Chapter 2 has been published by the author and was taken from the author with 
permission) 
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Sugar based ionic surfactants forming micelles are known to suppress electrospray 
ionization of various compounds due to decrease in surface tension upon micelle formation [1].  
For the first time, polymeric -D-glucopyranoside-based surfactants with different chain length 
and head groups  have been successfully synthesized, characterized and applied as compatible 
chiral selector in micellar electrokinetic chromatography-electrospray ionization-tandem mass 
spectrometry (MEKC-ESI-MS/MS).   First, the effect of polymerization concentration of the 
monomer, n-undecenyl α-D-glucopyranoside 4,6-hydrogen phosphate, sodium salt (-SUGP),  
was evaluated  by enantioseparation of one anionic compound [1,1′-binaphthyl-2,2′diyl-
hydrogen phosphate (BNP)] and one zwitterionic compound (dansylated phenylalanine) in 
MEKC-UV to find the optimum molar concentration for polymerization.  Next, MEKC-UV and 
MEKC-MS was compared for the enantioseparation of BNP. The influence of polymeric 
glucopyranoside-based surfactant head groups and carbon chain lengths on chiral Rs was 
evaluated for two classes of cationic drugs (ephedrine alkaloids and β-blockers). Finally, 
enantioselective MEKC-MS of ephedrine alkaloids and β-blockers were profiled at their 
optimum pH 5.0 and 7.0, respectively using ammonium acetate buffer and optimum polymeric n-
α-D-glucopyranoside surfactant.  The LOD for most of the enantiomers ranges from 10 ng/mL-
100 ng/ml with S/N of at least  > 3.0. 
2.1.  Introduction  
Increasing concerns on the resolution, sensitivity and structural identification of 
pharmaceutical drugs boosted the recent development of different types of chiral stationary 
phases for HPLC-MS [2-4].  However, over the years, CE-MS has emerged as a good alternative 
[5-7] because this microscale hyphenation technique provide efficient and low-cost  assays, 
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which is particularly attractive in clinical settings where reduced requirement of biological 
samples and solvent consumptions is a contributing factor in future analysis of biological 
activity, in vivo studies  and toxicity evaluation of pharmaceutical drugs.  
 The technique of CE-MS can be employed in two main approaches.  The first approach 
is most common in which simply the chiral selector or chiral surfactant is added to the volatile 
buffer solution (aka. EKC-MS or MEKC-MS) [5-7].  The second approach involves the use of 
bonded or immobilized chiral selector on the capillary column (aka, CEC-MS), which presents 
high sensitivity and greater sample loading capacity [8-10].  There is potential in both EKC-MS 
or MEKC-MS as well as CEC-MS to improve with the development of new chiral selectors for 
the separation and sensitive detection of a large number of chiral compounds.  Nevertheless, in 
all three aforementioned approaches of CE-MS, exotic chiral selector could be used to 
understand chiral separation and developed new chiral assays at much lower cost and high 
efficiency compared to HPLC-MS.   
Among the different chiral selectors added to the volatile buffers in EKC-MS, 
cyclodextrins [11] and crown ethers [12] are useful at low micromolar concentations, perhaps 
because they prevent ion suppression of the low molecular weight chiral selectors.  Polymeric 
amino acid based surfactants (aka. molecular micelles, MoMs) are a promising class of chiral 
selector, which has significant advantages for MEKC-MS over conventional low molecular mass 
chiral selectors (e.g., cyclodextrins and crown ethers).   First, they are covalently stabilized 
micellar aggregates with zero CMC, which can be used over a wide concentration range in 
MEKC-MS [13].  Second, due to high molecular weight they are not fragmented in the gas phase 
of ESI-MS [7,14,15]. Thus, the key to development of EKC-MS or MEKC-MS approaches is to 
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identify chiral selectors, which provide high separation selectivity and are MS compatible for 
sensitive detection of chiral compounds. 
In this work, the synthesis, characterization and application of four new sugar-based 
polymeric chiral surfactants is described for MEKC-MS. Although unpolymerized dodecyl 
glucopyranoside-based surfactants was previously reported for chiral separations in MEKC-UV 
[16], to the best of our knowledge, poly (n-alkyl-α-D-glucopyranoside, sodium salt) based 
surfactants have never been studied as chiral selectors for MEKC-MS. To achieve high 
separation selectivity, we investigated the polymerization concentration of the surfactants 
monomers, two different head groups and two different chain lengths of the surfactant as well as 
buffer pH. The chiral separation of 1,1′-binaphthyl-2,2′diyl-hydrogen phosphate (BNP) using the 
polymeric glucopyranoside-based surfactants in MEKC with UV and MS detection is compared. 
As illustrated, the use of optimum polymeric glucopyranoside based surfactant in MS gave 
higher enantioselectivity and efficiency with lower LOD for ten racemates. 
2.2. Materials and methods 
2.2.1 Reagents and chemicals 
Racemic mixture and individual isomers of ephedrine alkaloids (norephedrine, 
pseudoephedrine, ephedrine, and methylephedrine), β-blockers (atenolol, metoprolol, carteolol, 
and talinolol) and  1,1′-binaphthyl-2,2′diylhydrogen-phosphate (BNP), analytical-grade ammo-
nium acetate (as 7.5 M NH4OAc solution) and HPLC grade methanol (MeOH) were all obtained 
from Sigma-Aldrich (St. Louis MO ,USA).  Racemic mixture of dansyl phenylalanine was 
purchased from Santa Cruz Biotechnology (Dallas, Texas, USA). Sodium phosphate dibasic 
heptahydrate and sodium phosphate monobasic monohydrate were purchased from Fisher 
Scientific (Fair Lawn, NJ, USA). Ammonium hydroxide and acetic acid were supplied by Fisher 
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Scientific (Springfield, NJ, USA). All four vinyl surfactant monomers (i.e., octyl and 
undecylenyl phosphated and sulfated sugar surfactants) were polymerized under 20 M rad of 
60Co γ-radiation by Phoenix Memorial Laboratory (University of Michigan, Ann Arbor, MI). 
The chemicals and reagents used for synthesis, β-D-glucose pentaacetate (98%), sulfur 
trioxide pyridine complex (98%), 10-undecen-1-ol (98%), phenyl dichlorophosphate (95%), 
boron trifluoride etherate (46.5% BF3 basis), hexane, ethyl acetate (EtOAc), methanol 
anhydrous, tetrahydrofuran (THF) anhydrous, sodium sulfate (Na2SO4) pyridine anhydrous, 
dichloromethane anhydrous, Amberlyst® 15 hydrogen form were all purchased from Sigma-
Aldrich (St. Louis MO ,USA). The reagent, 7-Octen-1-ol (96%) was obtained from TCI America  
(Tokyo, Japan). Sodium bicarbonate (99.7%) and sodium hydroxide (NaOH, 50% v/v) were 
purchased from Fisher Scientific (Fair Lawn, NJ, USA).  Triply deionized (DI) water used in this 
experiment was obtained from Barnstead Nanopure II water system (Barnstead International, 
Dubuque, IA, USA). 
2.2.2 Synthesis of n-undecenyl and n-octenyl-α-D-glucopyranoside 4,6-hydrogen 
phosphate sodium salt, n-undecenyl and n-octenyl-α-D-glucopyranoside 6-hydrogen 
sulfate, monosodium salt.  
Both phosphated and sulfated sugar surfactants with eight and eleven chain lengths were 
synthesized with some modifications of the literature protocols [16,17,18] as detailed below.  
2.2.1 Synthesis of compounds 2 and 3 
The compounds 2 and 3 were synthesized according to step 1 of Scheme 2.1.  A solution of 
10-undecen-1-ol (3.9 mL,0.0195 mol) or  7-octene-1-ol (2.9 mL, 0.0195 mol), and 8.0 mL (0.065 
mol) boron trifluoride etherate were added to a stirring solution of 5g (0.013 mol) β-D-glucose 
pentaacetate in 50 mL dry dichloromethane under nitrogen. The resulting solution was then stirred 
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for 72 hrs under a blanket of nitrogen at room temperature.  The mixture was neutralized by 250 
mL saturated sodium bicarbonate solution (30 g, 0.36 mol) and then washed with 200 mL H2O. 
The lower organic layer was then dried with 10g Na2SO4 and concentrated in vacuo. The residue 
was purified by column chromatography [SiO2, hexane-EtoAc, 1:3] to yield pure compound 2 , n-
undecenyl α-D-glucopyranoside pentaacetate (1.9g, 29%) and compound 3, n-octenyl-α-D-
glucopyranoside pentaacetate (1.5 g, 25 %). 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.1.  Synthesis of poly n-alkyl α-D-glucopyranoside 4,6-hydrogen phosphate, sodium 
salt (α-SUGP) and poly n-alkyl α-D-glucopyranoside 6-hydrogen sulfate, monosodium salt (α-
SUGS). 
 
 
2.2.2 Synthesis of compounds 4 and 5 
The intermediate 2 and 3 were deacetylated in the presence of 20 mL anhydrous methanol 
and 1mL sodium methoxide solution (25%) under nitrogen for 3 hrs in ice bath. The resulting 
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reaction was then neutralized by 2g Amberlyst®15 hydrogen resin, filtered and concentrated in 
vacuo. The residue was purified by column chromatography [SiO2, EtoAc-MeOH, 10:0.5] to yield 
the pure intermediate 4, undecenyl α-D-glucopyranoside (1.1 g, 87%) and 5, n-octenyl α-D-
glucopyranoside (0.82 g, 87 %).  
2.2.3 Synthesis of product 6 and 7 
To synthesize product 6 and 7, phenyl dichlorophosphate (0.55 mL, 0.0037 mol) and dry 
triethylamine (0.69 mL, 0.0050 mL) was added to the solution containing intermediate 4 (1.1g, 
0.0033 mol) or intermediate 5 (0.82 g, 0.0028 mol) in 20 mL of dichloromethane.  The resulting 
solution was then stirred for 22 hrs under nitrogen to yield intermediate 6, n-undecenyl α-D-
glucopyranoside 4,6-phenyl phosphate and 7, n-octenyl α-D-glucopyranoside 4,6-phenyl 
phosphate. The resulting reaction was concentrated in vacuo and then purified by column 
chromatography [SiO2, hexane- EtoAc, 2:1] to yield the pure intermediate 6  (1.0 g, 64%) and 7 ( 
0.73 g, 61 %).  
2.2.4 Synthesis of product 8 and 9  
The product 8 n-undecenyl-α-D-glucopyranoside 4, 6-hydrogen phosphate, sodium salt and 
product 9, n-octenyl-α-D-glucopyranoside 4, 6-hydrogen phosphate, sodium salt were formed by 
dissolving intermediates 6 (1.0 g, 0.0021 mol) and 7 (0.73 g, 0.0017 mol) in 20 mL THF and by 
stirring for 24 hrs in the presence of 5 mL NaOH (10%) solution. Finally, THF was removed by 
vacuo and the resulting solution of each product was neutralized by 1 M HCl and extracted with 
ethyl acetate for 3 times. Next, the bottom aqueous solution of α-phosphate sugar surfactants were 
stirred for 1 day to remove trace ethyl acetate and lyophilized at  −50 °C collector temperature and 
0.05 mbar  pressure for 2 days to yield pure final product 8 (0. 8g, 90%) and 9 (0.56 g, 88%) 
2.2.5 Synthesis of product 10 and 11 
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To synthesize product 10 and 11, sulfur trioxide pyridine complex (0.63 g, 0.0040 mol) 
was added to the stirring solution containing 20 mL pyridine anhydrous and intermediate 4 (1.1 g, 
0.0033 mol) or intermediate 5 (0.82 g, 0.0028 mol). The resulting reaction was stirred for 
overnight under nitrogen to yield intermediate 10, n-undecenyl α-D-glucopyranoside 6-hydrogen 
sulfate and 11, n-octenyl α-D-glucopyranoside 6-hydrogen sulfate. The resulting reaction was 
concentrated in vacuo and then purified by column chromatography [SiO2, EtoAc-MeOH-H2O, 
10:2:1] to yield the pure intermediate intermediate 10 (0.9 g, 66%) and 11 (0.59 g, 64%).  . 
2.2.6 Synthesis of product 12 and 13 
 The product 12 n-undecenyl-α-D-glucopyranoside 6-hydrogen sulfate, monosodium salt 
and product 13, n-octenyl 6-hydrogen sulfate, monosodium salt was formed by the addition of 1 
mL NaOH (10%) solution and was lyophilized at −50 °C collector temperature and 0.05 mbar 
pressure for 2 days to yield pure final product 12 (0. 9g, 95%) and 13 (0.59 g, 95%). 
2.2.3  Characterizationof α-D-Sugar Surfactants 
The synthesized α-D-sugar surfactants with different chain lengths and head groups were 
characterized by use of nuclear magnetic resonance (1H-NMR) spectroscopy and ESI-MS. The 
details of the characterization of intermediates and products of the four synthesized sugar 
surfactants could be found in the Supporting Information Figs. A1–13. 
2.2.4  CE-MS instrumentation 
2.4.1 MEKC-UV and MEKC-MS conditions  
The direct infusion ESI-MS experiments to obtain the deprotonated molecular ions [M-
H]− of synthesized anionic sugar phosphated and sulfated surfactants could be found in 
Supporting Information Fig. A13a–d. The results discussed in Section 2.3.3 were carried out on 
an Agilent G1600 CE system (Agilent Technologies, Palo Alto, CA, USA) equipped with a 
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single quadrupole mass spectrometer. A typical procedure involves flushing 1 mg/mL of each 
synthesized surfactant (dissolved in triply deionized water) through a 60 cm long, 50 µm id, 
fused-silica capillary at 50 mbar to the ESI sprayer interface and monitoring the ESI-MS 
spectrum of the synthesized surfactant. The details of MEKC-UV and MEKC-MS/MS 
instrumentation could be found in Supporting Information. 
2.4.2 Preparation of running MEKC-MS buffer and analyte solutions.  
For chiral separations of dansylated phenylalanine (DNS-PA) and BNP in MEKC, the 
stock solutions were prepared in pure MeOH at 2.0 mg/mL and then were diluted to 1.0 mg/mL 
in MeOH/H2O (50/50, v/v) and pressure injected at 5 mbar for 10 s.  The separations were 
carried out under the normal polarity mode with an applied voltage of +20 kV.  The background 
electrolytes (BGEs) for enantiomeric separation of DNS-PA consisted of 12.5 mM each of 
NaH2PO4/Na2HPO4 buffer at pH 7.0.  The final running MEKC buffer solution was prepared by 
addition of 45 mM poly-α-D-UGP at various polymerization concentrations (20 mM, 50 mM, 75 
mM and 100 mM) to the BGE solution. The BGE for comparison of enantiomeric separation and 
sensitivity of BNP by MEKC-UV and MEKC-MS/MS was prepared in 20 mM NH4OAc 
solution by diluting 7.5 M NH4OAc stock solution in triply DI water and then adjusting to pH 
10.8 by 13.4 M ammonium hydroxide. The final running MEKC buffer solution was prepared by 
adding 15 mM poly (n-undecyl α-D-glucopyranoside 4,6-hydrogen phosphate, sodium salt) 
(poly-α-SUGP) to the BGE solution. 
All MEKC-UV and MEKC-MS/MS experiments were performed under the normal 
polarity mode with an applied voltage of +20 kV.  The ephedrine alkaloids, β-blockers and BNP 
were injected by applying a pressure of 5 mbar for 10 s. The final running MEKC-MS buffer for 
enantiomeric separation of BNP is the same as that in MEKC experiment. The BGEs for 
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Analyte 
fragmentor 
voltage (V) 
collision energy 
(eV) 
MRM transition 
(m/z) 
BNP 200 41 347.1 →  79.1 
pseudoephedrine 88 25 166.1 → 115.1 
ephedrine 88 25 166.1 → 115.1 
norephedrine 64 17 152.2 →  117 
methylephedrine 98 21 180.2  → 147.2 
atenolol 137 25 267.2  →  145.2 
metoprolol 107 17 268.2  →  116.2 
carteolol 83 17 293.2 → 237.2 
talinolol 98 13 364.3 → 308.3 
 
enantiomeric separation of ephedrine alkaloids and β-blockers were 25 mM NH4OAc prepared 
by diluting the 7.5 M NH4OAc stock solution in triply DI water and then adjusted to pH 5.0 by 
acetic acid or to pH 7.0 by ammonium hydroxide, respectively. The final running MEKC-ESI-
MS/MS buffer solutions for screening of enantioseparation were prepared by addition of 30 mM 
polymeric UGP, OGP, UGS or OGS to the BGE solutions. The composition and the flow rate of 
the sheath liquid were MeOH/H2O (80/20, %v/v) containing 5 mM NH4OAc at pH 6.8 and 5 
µL/min, respectively. Spray chamber parameters for BNP: nebulizer pressure: 3 psi, drying gas 
temp.: 250 °C, drying gas flow: 6 L/min; capillary voltage: -3000 V.  For ephedrine alkaloids 
and β-blockers: nebulizer pressure: 3 psi, drying gas temp.: 200 °C, drying gas flow: 8 L/min; 
capillary voltage: +3000 V. The fragmentor voltage, collision energy and product ion formations 
for these analytes were optimized by optimizer software using Agilent LC-MS in flow injection 
mode.  The details are tabulated in Table 2.1. The ESI-MS/MS detection was performed in the 
multiple reaction monitoring (MRM) negative ion mode. The sheath liquids were prepared by 
mixing 5 mM NH4OAc aqueous solution with MeOH/H2O (80/20, %v/v) for optimization study 
for BNP, ephedrines and β-blockers. 
 
Table 2.1. Fragmentor voltage, collision energy and product ion formations for the analytes from 
optimization experiments using flow injection ESI-MSa)  
 
 
 
 
 
 
 
61 
 
 
 
2.3.  Results and Discussion 
2.3.1 Physicochemical Properties 
Surface tension measurements were performed to evaluate the surface activity of all four 
α-D-glucopyranoside-based surfactant in water at various molar concentrations.  The surface 
tension of surfactants gradually decreases with increase in surfactant concentration and then 
reaches a plateau region, signaling micelle formation and the concentration of the break point 
represents the critical micelle concentration (CMC).  As shown in Table 2.2, the values of CMC 
decreases in the following order: α-SOGS > α-SUGS > α-SOGS > α-SUGP, (where α-SOGS is 
n-octenyl α-D-glucopyranoside 6-hydrogen sulfate, monosodium salt; α-SOGP is n-octenyl α-
glucopyranoside 4,6-hydrogen phosphate, sodium salt; and α-SUGS is n-undecenyl α-
glucopyranoside 6-hydrogen sulfate, monosodium salt), suggesting that sulfate head  group sugar 
surfactants have higher CMC than phosphate head group surfactants at equivalent surfactant 
chain length. This is perhaps due to increase in hydrogen bonding interactions, which decreases 
the repulsion between phosphate head groups within a micelle.  The trend for chain length is in 
accordance with increased hydrophobicity owing to the extension of hydrocarbon chain from C8 
to C11.  The CMC is lower for longer chain (i.e., α-SUGS and α-SUGP), because it facilitates 
micelles formation at lower concentration and hence lower CMC.  Aggregation number and 
polarity of both unpolymerized micelle and polymerized form of the four surfactants were 
calculated as reported earlier for amino acid surfactants [19].   With increase in chain of α-D-
glucopyranoside surfactants for each head group, aggregation increases and polarity decreases. 
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Table 2.2. Physicochemical properties of n-alkenyl α-D-glucopyranoside monomers and 
polymers 
 
 
 
 
 
 
 
2.3.2   Effect of Polymerization concentrations on chiral resolution and run time   
It is well known that ionic MoMs facilitate the polymerization to produce high molecular 
weight polymers. The chiral recognition ability of MoM was characterized using two model test 
solutes (DNS-PA and BNP) using optimum pH and optimum buffer type by varying the 
analytical concentration of α-SUGP monomers. The polymerization experiment was performed 
by varying the analytical concentrations at 20 mM, 50 mM, 75 mM and 100 mM α-SUGP at a 
fixed dose of 20 Mrad of 60Co-γ-radiation.  Several interesting trends are noted in Fig. 2.1 when 
comparing the resolution and retention of two enantiomeric pairs.  First, note that due to high 
reactivity of α-SUGP monomers, even when polymerized at 20 mM (i.e., 5x CMC) provide 
significant retention of both chiral analyte was observed.  Second, micelles formed using higher 
analytical concentration of α-SUGP always resulted in longer run times irrespective of the type 
of chiral solute.  This trend is primarily due to increase in aggregation number and hence 
hydrophobicity of the micelle.  Note, that this effect of increasing migration time is less 
pronounced for BNP, (Fig. 2.1A right panel) compared to DNS-PA (Fig. 2.1B left panel).   
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Our hypothesis regarding the data shown in Fig. 2.1 is that when poly-α-SUGP micelles 
are used for chiral separation, the achiral hydrophobic tail, which is linked to a chiral linker (i.e., 
sugar moiety) does not participate in chiral separation, but it does contribute to experimentally 
observed retention of both enantiomers. The relatively higher increase in retention of DNS-PA 
compared to BNP suggests that the former enantiomeric pair is mainly retained by extensive 
contribution from nonenantioselective hydrophobic site of the MoMs.  Consequently, the 
increase in enantiomeric resolution is smaller for DNS-PA than for BNP. Third, the 
enantioselectivity of BNP was observed at all surfactant concentration used for polymerization.  
On the other hand, the DNS-PA requires the use of micelles, which are formed using at least 12.5 
times the CMC of α-SUGP to show any hint of chiral resolution (Rs =0.8).  To test the 
hypothesis on the data acquired above, a quantitative assessment of enantioselective versus non-
enantioselective interaction in MEKC will be performed in our future communication using 
linear free energy relationship.   
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Fig.2.1. Effect of polymerization concentrations of SUGP surfactant monomers on chiral Rs of 
zwitterionic compound (dansyl phenylalanine) and anionic compound (BNP) in MEKC.  
Conditions: Panel (A): 56 cm effective length (375 µm O.D., 50 µm I.D.) fused silica capillary; 
sample concentration: 1.0 mg/mL in MeOH/H2O (50/50).   Buffer: 12.5 mM NaH2PO4 +12.5 
mM Na2HPO4, pH 7.0, 45 mM  poly--SUGP.   Applied voltage: +20 kV, injection: 5 mbar, 10 
s.   Panel (B) sample concentration: 1.0 mg/mL in MeOH/H2O (50/50). Buffer: 20 mM NH4OAc, 
pH 10.8, 15 mM poly--SUGP. Conditions for applied voltage, injection and capillary 
dimensions are the same as panel A.  Peak identification: 1= R- DNS-PA, 1’ = S-DNA-PA, 2 = 
R-BNP, 2’ = S’-BNP. 
 
2.3.3 Direct infusion ESI-MS of model test analyte 
Our surface tension data suggest that sugar-based surfactants forming polymeric micelles 
are less surface active (surface tension ~ 54 mN/m) and its surface tension is fairly constant in 
the studied range from 1-50 mM, compared to the corresponding unpolymerized micelles 
(surface tension ~ 30 mN/m at the CMC) (data not shown).  Thus, the lower surface activity of 
polymerized sugar micelles should reduce interferences in electrospray process.  Therefore, these 
findings may have significant implications for sensitive CE-MS analysis of chiral compounds.  
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Fig. 2.2 compares the positive ion ESI-MS spectra (arbitrary y-units) of model test analyte, 
protonated DNS-PA (m/z = 397) in the absence (2A) and presence of monomeric (unpolymerized 
α-SUGP micelle, 2B) and polymeric (poly-α-SUGP, 2C).  
 
 
 
 
 
 
 
 
 
Fig. 2.2. Comparison of ESI-MS signal of DNS-PA obtained by direct infusion positive-ion ESI-
MS in the presence of (A) no surfactant,(B) 50 mM unpolymerized α-SUGP, and (C) 50 mM 
poly-α-SUGP. 
 
 
Consistent with the surface tension data, significant ESI-MS suppression of protonated 
form of model test analyte, dansylated phenyl alanine (DNS-PA) was observed and the signal 
abundance of DNS-PA reduces from 39872 to only 3695, which is ~10% in the presence of 50 
mM of unpolymerized (α-SUGP, Fig.2.2B).  However, as evident from the right panel, the use of 
50 mM poly-α-SUGP in the positive ion ESI-MS also suppresses the signal intensity of DNS-
PA, but still 57% of the signal intensity (abundance = 22184) was observed (Fig.2.2C).  This 
suggest that unlike commonly used low molecular weight selectors (e.g., sulfated β-CD, 
vancomycin, crown ether), direct infusion of the poly-α-SUGP into the ESI-MS does not 
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contaminate the ion source.  Furthermore, no frequent MS cleaning is required.  The absence of 
any monomer peak when infused with 50 mM poly-α-SUGP and no polymer peak observed at 
any upper m/z of the ESI-MS (Fig.2.1C) confirmed that the covalent bond formed between sugar 
surfactant monomers indeed generate a high molecular weight micelle, which is difficult to 
ionize during electrospray process.  While 50 mM of chiral selector is only used for weakly 
binding analyte, we can state that for strongly binding analyte we could achieve excellent S/N, 
allowing trace level chiral drug detection as demonstrated in Section 2.3.4.  Even with off-line 
MALDI-TOF we were unable to see any dimer or trimer peak of poly-α-SUGP. Direct infusion 
of poly-α-SUGP in the electrospray at much lower concentration (e.g., 25 mM), the signal 
intensity of DNS-PA was restored to 80% of its original value (data not shown).  
2.3.4 Comparison of MEKC-UV with MEKC-MS for chiral separations  
The UV absorbance is the most commonly used detection method for majority of chiral 
separations in MEKC. Although chiral MEKC-UV is inherently less sensitive than MEKC-MS, 
but the use of low molecular weight chiral selectors in MEKC-ESI-MS is detrimental and has 
several limitations [20].  For example, the low molecular weight selector produces abundant gas-
phase molecular ions, which participate in charge competition as well as ion pair formation in the 
sprayer suppressing the analyte signal. It should be noted that the high molecular weight chiral 
polymeric surfactant (aka. MoMs) is nonvolatile but they are not fragmented in the ESI source. 
The benefit of using high molecular weight (e.g., >10 kDa) MoMs as chiral selector for MS is 
that the formation of covalent bond between vinyl terminated monomers in MoMs prevent 
fragmentation in the electrospray. Furthermore, MoMs are difficult to ionize and they migrate in 
a direction, which is opposite to EOF. Thus, the use of higher molecular weight chiral selector 
despite of being nonionizable and nonvolatile could provide very useful information about the 
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mass and structure associated with enantioseparation of unknown chiral compounds. On the 
other hand, UV cannot solve such identification problems. In fact, when samples containing 
contaminants are analyzed in MEKC-UV, several unknown peaks appear or coelutes in the 
electropherogram. 
The binaphthyl derivative such as BNP is extensively used as asymmetric ligands in the 
synthesis of chiral catalysts and also employed as chiral probe solute in MEKC to evaluate the 
enantioselectivity of chiral stationary phase [21].  As is shown clearly in Fig. 2.3A and B, 
baseline chiral Rs has been achieved for BNP using poly-α-SUGP with ammonium acetate buffer 
in MEKC-UV and MEKC-MS/MS, respectively. However, MEKC-MS/MS using high 
molecular weight poly-α-SUGP provide higher efficiency and signal to noise ratio (S/N) even 
when injected at concentration ten folds lower than MEKC-UV.  The levels of repeatability, 
which are expressed as the precision obtained under same operating condition was briefly 
investigated. Using BNP as a model test analyte for ten consecutive runs, the %RSD of 
migration time, peak area and resolution were 2.3, 20.5, and 2.2, respectively, without any 
normalization (Supporting Information Fig. A14). 
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Fig. 2.3  Comparison of MEKC-UV (A), and MEKC-MS/MS (B) for chiral separation of  BNP.  
Conditions: (A) 56 cm effective length (375 µm O.D., 50 µm I.D.) fused silica capillary.  BNP 
concentration: 1.0 mg/mL in MeOH/H2O (50/50). Buffer: 20 mM NH4OAc, pH 10.8, 15 mM 
poly-α-D-UGP. Applied voltage: +20 kV, injection: 5 mbar, 10 s.  The capillary dimension in  
(B) are the same as (A) except for 60 cm effective length fused silica capillary. BNP 
concentration: 0.1 mg/mL in MeOH/H2O (50/50, v/v).  Spray chamber parameters: nebulizer 
pressure: 3 psi; drying gas temp: 250 °C, drying gas flow rate: 6 L/min; capillary voltage: -3000 
V; fragmentor voltage: 200 V, collision energy: 41 eV, MRM transition:  347.1 -> 79.1.  Sheath 
liquid: MeOH/H2O (80/20, v/v), 5 mM NH4OAc, pH 6.8 with a flow rate of 0.5 mL/min.  Peak 
identification: 1 = R-BNP, 1’ = S’-BNP. 
 
 
2.3.5 Effect of chain length and head groups of sugar surfactants on chiral separations 
Four polymeric sugar surfactants with two different head groups (phosphate and sulfate) 
and two chain lengths (C8 and C11) were selected to separate ephedrine alkaloids under the same 
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CE conditions to find out the optimum head group and chain length. The bar plots in Fig. 2.4 A 
and 2.4B compare the chiral Rs of four ephedrine alkaloids and four β-blockers, respectively, 
when the four polymeric sugar surfactants were used as chiral selector in MEKC-MS/MS.  From 
Fig. 2.4A, polymeric α-SUGP has the highest chiral Rs values among all of the four surfactants 
for all ephedrine alkaloids. Note, poly α-SUGS gave baseline chiral Rs for norepehdrine only, 
whereas partial Rs was obtained for methylephedrine and norephedrine using α-SUGS and α-
SOGS, respectively. However, no chiral Rs was observed when using polymeric α-SOGP.    
Similarly, in Fig. 2.4B, the highest chiral Rs value was again achieved by poly α-SUGP 
for the four β-blockers.  Using the other three polymeric surfactant, only atenolol provided 
partial chiral Rs irrespective of the chain length and head group.   Therefore, it could be 
concluded that poly α-SUGP is the optimum chiral selector among the four surfactants for the 
enantioseparations of ephedrine alkaloids and β-blockers. Furthermore, it is noted that poly α-
SUGP with phosphate head group and C11 chain length are better resolved than poly α-SUGS 
using sulfate head group with equivalent chain length with regard to enantioseparations of BNP 
(data not shown). This could be explained by the fact that phosphate head group has a more rigid 
bicyclic structure than sulfate group [16], which contributes to higher enantioseparation and 
better interaction between poly α-SUGP and the analytes. 
 
 
 
 
 
 
70 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.4 Bar plots  illustrating the effect of chain length and head groups of sugar surfactants on 
chiral Rs of ephedrine alkaloids in MEKC-MS/MS.  Conditions: 75 cm long (375 µm O.D., 50 
µm I.D.) fused silica capillary. Buffer: 25 mM NH4OAc, pH 5.0, 30 mM polymeric SUGP, 
SUGS, SOGP and SOGS.  Applied voltage, +20 kV, injection, 5 mbar, 10 s. Spray chamber and 
sheath liquid conditions are the same as Fig. 3.  Sample concentration: 10 µg/mL in MeOH/H2O 
(10/90, v/v). (B) Bar plots illustrating the effect of chain length and head groups of sugar 
surfactants on chiral Rs of β-blockers in MEKC-MS/MS. Conditions and spray chamber 
parameters are the same as Fig. 2 except 25 mM NH4OAc adjusted to pH 7.0 by NH4OH. 
Fragmentor voltage, collision energy and product ion formations of ephedrine and β-blockers are 
listed in Table 2.2. 
2.3.6 Effect of buffer pH 
The effect charge on the chiral analyte and chiral polymeric surfactant as well as the 
magnitude of the electroosmotic flow (EOF) are greatly affected by the pH of the volatile BGE.   
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According to previous study in our group using amino acid based polymeric surfactants [19, 22-
23], the enantioseparation of ephedrine alkaloids and β-blockers were achieved at pH 6.0 and 
8.8. respectively using ammonium acetate buffer. Thus, pH ranges were investigated from 5.0 to 
6.0 for ephedrine alkaloids and 6.0 to 9.5 for β-blockers using poly α-SUGP. 
Fig. 2.5A shows the chiral Rs of ephedrine alkaloids vs. buffer pH.  The Rs value of four 
ephedrine alkaloids decreased with the increase of pH from 5.0-6.0. This is because increasing 
pH increases the EOF resulting in faster electroosmotic mobility and weaker interactions with 
poly α-SUGP.  The chiral Rs of β-blockers vs. buffer pH is shown in Fig. 2.5B. As stated earlier, 
the increase in EOF of ammonium from 5.0 to 6.0 caused decreasing enantioseparation of 
ephedrine alkaloids.  However, the β-blockers seem to encounter the most favorable (fastest) 
EOF at pH 7.0 compared to pH 6.0.  Further increase in pH from 7.0 to 9.5 (by titration with 
NH4OH) caused an increase in ionic strength because at higher pH values the buffer solution also 
contains excess of ammonium ions and hydroxide ions resulting in much slower electroosmotic 
mobility. Consequently increasing migration time and decreasing the chiral Rs.  Thus, the 
majority of β-blockers provided highest Rs value at pH 7.0. 
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Fig. 2.5 (A) Bar plots illustrating the effect of pH on chiral Rs of ephedrine alkaloids in MEKC-
MS/MS.  Buffer conditions and spray chamber parameters are the same as in Fig. 2.3 (A) except 
30 mM poly-α-D-UGP was used at pH 5.0, 5.5 and 6.0.  (B) Bar plots illustrating the effect of 
pH on chiral Rs of β-blockers in MEKC-MS/MS. Conditions and spray chamber parameters are 
the same as in Fig. 2.4 (B) except 30 mM poly-α-D-UGP was used in the pH range of 6.0 to 9.5. 
 
 
2.3.6.1 Optimum chiral MEKC-MS/MS of ephedrine alkaloids and beta blockers 
Using 25 mM poly α-SUGP at optimum pH 5.0 in MEKC-MS/MS the enantioresolutions 
and enantioselectivity of four ephedrine alkaloids follows the decreasing order:  
(methylephedrine > epdedrine ~ norephedrine  > pseudoephedrine)  in MEKC-MS/MS (Fig.2.6).   
The enantiomer pair of ephedrine and pseudoephedrine has the same precursor and the daughter 
ions.  Thus, neither mass (accurate mass) nor MS/MS could distinguish the two pairs of 
enantiomers.  The simultaneous baseline separation based on MEKC retention of 
pseudoephedrine from ephedrine prevents any cross talk of daughter ions.  This would allow the 
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two isomers to be quickly identified and quantitated in biological samples.  The pseudoephedrine 
enantiomers has partial Rs of 0.9 but still it was well resolved from ephedrine enantiomers.  The 
other three enantiomers were baseline separated with methylephedrine being the longest retained 
and norephedrine is the shortest retained among all four chiral analytes.   
Fig. 2.7 shows the electropherograms of the enantioseparations of four β-blockers: 
atenolol, metoprolol, carteolol and talinolol using the optimum 25 mM poly α-SUGP at optimum 
pH 5.0.  Interestingly, polymeric SUGP is capable of separating these β-blockers based on their 
hydrophobicity (log P).  Note that the migration time increases in the order of increasing 
retention: atenolol < carteolol < metoprolol < talinolol, which is consistent with the log P 
(atenolol: 0.34<carteolol: 1.34 < metoprolol < 1.63 < talinolol: 2.98).  However, Rs and α trends 
do not seem to follow the log P order. The chromatograms shown in Supporting Information 
Table 2.1 indicate that LOD is analyte dependent and ranges from 10 – 100 ng/mL, which could 
be further improved using preconcentration techniques. 
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Fig. 2.6  Electropherograms for enantioseparation of ephedrine alkaloids using sugar surfactant 
with optimum head group and chain length at optimum pH 5.0 in MEKC-MS/MS.  Conditions 
and spray chamber parameters are the same as Fig.2.5 (A) except 30 mM poly-α-D-UGP was 
employed.  Peak identifications:  1 = (1R,2S)-(-)norephedrine, 1’ = (1S,2R)-(+)norephedrine,  2  
= (1R, 2R ) (-)pseudoephedrine,  2’ = (1S,2S)(+) pseuodephedrine;  3 = (1R,2S)-(-)ephedrine, 3’ 
= (1S,2R)-(+)ephedrine;  4 = (1R,2S)-(-)N-methylephedrine, 4’ = (1S,2R)-(+)N-methylephedrine.   
 
 
 
 
 
 
 
 
Fig. 2.7  Electropherograms for enantioseparation of β-blockers using sugar surfactant with 
optimum head group and chain length at optimum pH 7.0 in MEKC-MS/MS.  Conditions and 
spray chamber parameters are the same as Fig.5 (B) except 30 mM poly-α-D-UGP was 
employed. Peak identifications:  1,1’ = atenolol, 2,2’ = carteolol, 3,3’ = metoprolol, 4,4’ = 
talinolol.   For each β-blocker the R-enantiomer always eluted first than S-enantiomer.  
 
 
2.4 Concluding remarks 
Four polymers of α-D-glucopyranoside based surfactants were synthesized, characterized 
and screened for chiral analysis in MEKC-MS. The use of polymers instead of the monomers of 
the same surfactants shows significantly enhanced signal intensity in ESI-MS. The addition of 
poly-α-SUGP at pH 5.0 and pH 7.0 to the MEKC-MS buffer provided the optimum separation of 
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two classes of analytes such as ephedrine alkaloids and β-blockers, respectively. While only ten 
runs were performed to test the repeatability of chiral analysis, the results could be improved 
further using absolute migration time and standardization of peak areas. Furthermore, the use of 
a chemically modified capillary with buffer containing sugar surfactant polymers as pseudophase 
is in progress in our laboratory. 
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Chapter 3 
 
Chiral Capillary Electrophoresis-Mass Spectrometry:  Turning an Analytical 
Technique into High Throughput Screening of Chiral Compounds Using Novel 
Polymerized β-D-Glucopyranoside Surfactants 
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Polymeric glucopyranoside based surfactants have been successfully employed as chiral 
selector in micellar electrokinetic chromatography-mass spectrometry (MEKC-MS/MS). The β-
D-alkyl-glucopyranoside based surfactants, containing charged head groups such as sodium-n-
alkyl β-D-glucopyranoside 4,6-hydrogen phosphate, sodium salt and n-alkyl β-D-
glucopyranoside 6-hydrogen sulfate, monosodium salt were able to enantioseparate 21 cationic 
drugs and 8 binaphthyl atropisomers (BAIs) in MEKC-MS/MS, which promises to open up the 
possibility of turning an analytical technique into high throughput screening of chiral 
compounds. Physicochemical properties and enantioseparation capability of β-D-
glucopyranoside based surfactants with different head groups and chain lengths were compared.  
Moreover, the comparison of α- and β-D-glucopyranoside 4,6-hydrogen phosphate, sodium salt 
were further explored with regard to enantioseparations of ephedrine alkaloids and b-blockers.  
The concept of multiplex chiral MEKC-MS for high throughput quantitation is demonstrated for 
the first time in scientific literature. 
 
3.1 Introduction 
Chirality on analytical scale is a major concern in pharmaceutical industry due to 
different pharmacological activities of enantiomers such as pharmacokinetic and 
pharmacodynamics studies [1].  Nearly 56% of the pharmaceuticals currently used are chiral 
compounds.  There has been eminent push in developing racemic chiral switches, still nearly 
50% of these synthetic drugs used therapeutically are racemates [2-3].   Furthermore, the US 
Food and Drug administration as well the International Conference of Harmonization 
recommends that a given methodology for quality control of a new chiral drug must be able to 
detect at least 0.1 % of enantiomeric impurity in an active enantioselecvtive pharmaceutical [4].  
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The UV detection is the mostly used for chiral CE mainly due to its simplicity and low 
cost.  However, lack of sensitivity due to short path length (i.e.,25-100 m), matrix effects in 
biological fluids, lack of structural information have limited the use of this detector for analysis 
of chiral compounds.  Therefore, there is an urgent need to develop new approaches not only for 
chiral separation but also achieving high detection sensitivity of chiral compounds used in 
therapeutics and diagnostics.   
Mass spectrometry (MS) is a useful approach for achieving low detection sensitivity of 
enantiomers.  Furthermore, extract ion electropherogram in single ion monitoring mode provides 
matrix free detection of enantiomers in biological fluids and identify the enantiomers by its mass 
to charge ratio (m/z) ratio as long as they are well separated and structural information by 
MS/MS fragmentation pattern.  While chiral reagents (cyclodextrins, macrocylic antibiotics and 
crown ethers) are very popular and effective chiral selectors but none of these aforementioned 
low molecular weight CE-UV reagents are fully compatible with MS and the loss of sensitivity 
due to ion suppression is still a problem.  To avoid this problem, several approaches are 
employed: (a) counter migration techniques in which chiral selector migrate away from the 
detector [5], (b) partial filling technique in which only a part of the capillary is filled with a plug 
of chiral selector [6], (c) low flow sheathless interface [7]; (d) high molecular weight polymeric 
surfactants [8].  
The ability of molecular micelles MoMs as reagents for chiral separations (CE or MEKC) 
is explored for just over two decades.  Wang and Warner [9], Shamsi and Warner [10], Billiot 
and Warner [11-12], are among the first few scientists to discuss the enantioselectivity of chiral 
amino acid (AA) and dipeptide (DP) polymeric surfactants for chiral separations in MEKC.  
Later, a new generation of amino acid (AA) based MoMs with carbamate linker was introduced 
81 
by Akbay  and Shamsi [13] , which improve enantioresolution and decrease tailing of a variety 
of basic drugs (e..g, ephedrine alkaloids and -blockers) [13, 14].   The development of amino 
acids MoMs containing amide or carbamate linkers with different head group charge and chain 
length has enabled the synthesis of many new AA based MoMs for fundamental studies and their 
separation performance is well demonstrated in  MEKC with UV detection [15].   
The use of AA-based MoMs as pseudostationary phase was proposed for chiral MEKC-
MS by our research group as early as 2001 [8].    In spite of higher degree of MS compatibility of 
using AA and dipeptide based MoMs for MEKC-MS, there is a need to develop new chiral 
selectors to extend the window for separations of structurally diverse chiral analytes.  In this 
work, we introduce a new generation of MS compatible vinyl terminated -D glucose based 
surfactants (n-alkenyl-glucopyranoside) as chiral MoMs for chiral MEKC-MS.   Several key 
advantages of this  new generation of glucopyrnaoside based MoMs  are noted: (a) multiple 
stereogenic centers favors enantioseparation of diverse group of analytes; (b) environmental 
friendly and low surface tension, thus high surface activity compared to their corresponding 
monomers;  (c) due to zero critical micelle concentration (CMC) the chiral MoMs can be used at 
significantly lower concentration resulting in lower operating current for CE-MS;  (d)  separation 
of multichiral center compounds using only a single chiral selector is possible.  In particular, the 
advantages (b) and (c) noted above enables this class of MoMs to be fully compatible with 
electrospray ionization (ESI)-MS.  Several enantioseparation paramaters such as head group 
charge, chain length and anomeric configurations of n-alkyl -D- glucopyranodside is varied to 
understand the effect of these parameters on chiral recognition for a diverse group of cationic 
compounds (primary amines, secondary, amino alcohols and quaternary amines) as well as  
various structural analogs of anionic and neutral biaryl atropisomers (BAIs).  New strategy based 
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on multiplex injection allowing highthroughput quantitation of enantiomers in MEKC-MS is 
demonstrated for the first time. 
 
3.2. Materials and methods 
3.2.1 Reagents and chemicals 
Racemic mixture of 1,1′-binaphthyl-2,2′-diyl hydrogen phosphate (BNP), 1,1'-bi-2-
naphthol (BOH), 1,1'-binaphthalene-2,2'-diamine (BNA) and all 23 cationic drugs, analytical-
grade ammonium acetate (as 7.5 M NH4OAc solution), HPLC grade methanol (MeOH) and 
acetic acid (99.7%) were supplied by Sigma-Aldrich (St. Louis MO, USA).  Five racemic 
mixture of biaryl atropisomers (BAI) [(1-(2-amino-3-chloro-6-methylphenyl) naphthalen-2-ol, 1-
(2-amino-3-chloro-5-methylphenyl) naphthalen-2-ol, 1-(2-amino-3-bromo-4-methylphenyl) 
naphthalen-2-ol, 1-(2-amino-3,4,5-trichloro-phenyl) naphthalen-2-ol, and 1-(2-amino-3-
bromophenyl)-6-methoxy naphthalen-2-ol)] were kindly provided by Prof. Daniel W. 
Armstrong’s laboratory (University of Texas at Arlington, Arlington, TX). Ammonium 
hydroxide (25%) was obtained from Acros organics (NJ, USA).    
The chemicals and reagents used for synthesis, β-D-glucose pentaacetate (98%), sulfur 
trioxide pyridine complex (98%), 10-undecen-1-ol (98%), phenyl dichlorophosphate (95%), 
boron trifluoride etherate (46.5% BF3 basis), hexane, ethyl acetate (EtOAc), methanol 
anhydrous, 1,4-dioxane anhydrous, sodium sulfate (Na2SO4), pyridine anhydrous, 
dichloromethane anhydrous,  Amberlyst® 15 hydrogen form were purchased from Sigma-
Aldrich (St. Louis MO, USA). The reagent, 7-octen-1-ol (96%) was purchased from TCI 
America (Tokyo, Japan).  Sodium bicarbonate (99.7%) and sodium hydroxide (NaOH, 50% v/v) 
were obtained from Fisher Scientific (Fair Lawn, NJ, USA).  Triply deionized (DI) water used in 
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the experiments was obtained from Barnstead Nanopure II water system (Barnstead 
International, Dubuque, IA, USA). 
3.2.2 Synthesis of α- and β-D sugar surfactants  
Both eight and eleven carbon β-D-phosphated and sulfated sugar surfactants were 
synthesized according to the modified protocols of synthesizing α-D-glucopyranoside-based 
surfactants [16-19].   
Product 2 and 3.  To synthesize  β configuration of sugar surfactants, a solution of 10-
undecen-1-ol (3.9 mL,0.0195 mol) or 7-octene-1-ol (2.9 mL, 0.0195 mol), and 2.1 mL (0.0169 
mol) boron trifluoride etherate were added to a stirring solution of  5g (0.013 mol) β-D-glucose 
pentaacetate in 50 mL dry dichloromethane. The resulting solution was then stirred for 18 hrs 
under a blanket of nitrogen at room temperature.   Next, the mixture was neutralized by adding 250 
mL saturated sodium bicarbonate solution (30 g, 0.36 mol) and then washed with 200 mL H2O.   
The lower organic layer was then dried with Na2SO4 and concentrated in vacuo.  
Product 4 and 5. Next, the crude undecenyl or octenyl-β-D-glucopyranoside acetate was 
deacetylated in the presence of 20 mL anhydrous methanol and 1mL sodium methoxide solution 
(25%) under nitrogen for 3 hrs in ice bath. The resulting reaction product was then neutralized by 
2g Amberlyst®15 hydrogen resin, filtered and concentrated in vacuo. To yield pure β-D undecenyl- 
or β-D-octenyl-glucopyranoside, the residue containing a mixture of both α-and β-D-
glucopyranoside was purified by flash column chromatography [SiO2, EtoAc-MeOH, 10:0.5].  The 
eluent volume collection started at a point when the spot appeared on the TLC plate.  To determine 
the pure β-product in the eluent, first a series of 1H-NMR optimization was conducted by 
collecting first ten tubes (i.e.,110 mL) of eluent each time (data not shown).  It was found that the 
first two sets of collection, i.e., first twenty tubes (~ 220 mL) contains predominately β-D 
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glucopyranoside and very little α product (less than 5%) as verified 1H-NMR spectrum (Fig. S3). 
Next, the phosphorylation and sulfation steps to obtain products (6,7,10,11) were performed as 
reported previously [16-19]. 
Product 15.  To synthesize α-configuration of sugar surfactants, only the first two steps 
[Scheme 3.1] were modified as discussed below. Five grams (0.013 mol) of β-D-glucose 
pentaacetate was stirred in 50 mL anhydrous dichloromethane.  Aliquots of 3.9 mL 10-undecen-
1-ol (0.0195 mol) and 8.0 mL (0.065 mol) boron trifluoride etherate were added to the stirring 
solution. The resulting reaction was then allowed to proceed at room temperature for 72 hrs 
under a blanket of nitrogen.  Next, 250 mL saturated sodium bicarbonate solution (30 g, 0.36 
mol) was used to neutralize the reaction before the reaction mixture was washed with 200 mL 
H2O.   The lower organic layer was then dried with 10 g Na2SO4 and concentrated in vacuo.   
The deacetylation reaction to obtain α-D-undecenyl glucopyranoside is the same as synthesizing 
β-D-undecenyl glucopyranoside except when performing flash column chromatography [SiO2, 
EtoAc-MeOH, 10:0.5] all of the eluent was collected after the appearance of spot on the TLC 
plate.  The next two steps to obtain α-D-undecenyl glucopyranoside 4,6-hydrogen phosphate, 
sodium salt (product 16) are the same as reported previously [16-19].  
Four vinyl surfactant monomers (ie., n-undecenyl β-D-glucopryanoside) with sulfated 
and phosphated head groups (products 8,9,12,13, Scheme 1) and one vinyl surfactant monomer, 
α-D-undecenyl glucopryanoside (product 16,  Scheme 1) with phosphated head group were 
polymerized to obtain products (17-21) using a total dose of 20 M rad of 60Co γ-radiation by 
Breazale nuclear reactor laboratory (Pennsylvania State University, University Park, PA ). 
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Scheme 3.1  Synthesis scheme for   poly(n-undecyl α-D-glucopyranoside 4,6-hydrogen 
phosphate, sodium salt 21) (poly--SUGP), poly(n-undecyl β-D-glucopyranoside 4,6-hydrogen 
sodium phosphate, sodium salt 17) (poly--SUGP), poly(n-undecyl β-D-glucopyranoside 6-
hydrogen sulfate, monosodium salt 18) (poly--SUGS),  poly (n-octyl -D-glucopyranoside 4,6-
hydrogen phosphate, sodium salt 19), (poly--SOGP),  poly(n-octyl -D-glucopyranoside 6-
hydrogen sulfate, monosodium salt 20) (poly--SOGS).    
 
 
3.2.3 CE-MS instrumentation 
3.2.3.1 MEKC-MS conditions  
All MEKC-ESI-MS/MS experiments were carried on an Agilent 7100 CE system 
(Agilent Technologies, Palo Alto, CA, USA) coupled to an Agilent 6410 series triple quadrupole 
mass spectrometer (Agilent Technologies, 207 Palo Alto, CA).  The CE instrument consisted of 
an on line diode array detector and 0-30 kV high voltage power supply.  Mass spectrometer was 
equipped with Agilent CE-MS adapter kit (G1603A), an Agilent CE-ESI-MS sprayer kit 
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(G1607) and Agilent 1100 series isocratic HPLC pump to deliver the sheath liquid with a 1:100 
splitter.  Nitrogen was used as nebulizing gas and drying gas. The Agilent ChemStation software 
and Agilent Mass-Hunter Workstation (version B.02.01) were used for instrumental control and 
data acquisition as well as for qualitative and quantitative data analysis.  The fused silica 
capillary with 60 cm effective length (375 μm O.D., with 50 µm I.D) used for MEKC-MS/MS 
experiments was purchased from Polymicro Technologies (Phoenix, AZ, USA). The applied 
voltage was +20 kV with injection of 5 mbar, 10 s.  All samples were prepared in 100 µg/mL in 
MeOH/H2O (10/90, v/v).  The composition and the flow rate of the sheath liquid were 
MeOH/H2O (80/20, %v/v) containing 5 mM NH4OAc and 5 µL/min, respectively. Spray 
chamber parameters: nebulizer pressure: 3 psi, drying gas temp.: 200 °C, drying gas flow: 8 
L/min; capillary voltage: +3000 V. The fragmentor voltage, collision energy and product ion 
formations for all the analytes were optimized using optimizer software using Agilent LC-MS in 
flow injection mode.  
 
3.2.3.1.1 Multisegment injection configuration  
All series of hydrodynamic injection were performed at 5 mbar using alternating 
segments of sample/internal standard (BNP and R-BOH) and MoMs spacer (BGE containing 15 
mM poly-β-SUGS) was programed in the injection table of Agilent ChemStation software.  A 4-
sample segment format used for the quantitation of BNP was set up in the following injection 
sequence: (1) 10 s sample (100 µg/mL BNP and 250 µg/mL of R-BOH), 120 s spacer; (2) 10 s 
sample (200 µg/mL BNP and 250 µg/mL of R-BOH), 120 s spacer; (3) 10 s sample (300 µg/mL 
BNP and 250 µg/mL of R-BOH), 120 s spacer; (4) 10 s sample (500 µg/mL BNP and 250 µg/mL 
of R-BOH), 120 s spacer.  The total time injection time was about 9 min.  
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3.2.3.2 CE-MS conditions and preparation of buffers and analyte solutions 
For chiral separations of all cationic drugs and binaphthyl derivatives, the stock solutions 
were prepared in pure methanol at 5.0 mg/mL and then were diluted to 100 µg/mL in 
MeOH/H2O (10/90, v/v) and pressure injected at 5 mbar for 10 s.  
All MEKC-MS/MS experiments were performed under the normal polarity mode with an 
applied voltage of +20 kV.  The ESI-MS/MS detection was performed in the multiple reaction 
monitoring (MRM) positive ion mode for cationic drugs and negative ion mode for binaphthyl 
derivatives.  The MRM transitions were optimized using Optimizer software using flow injection 
HPLC (Table S1).  The BGEs for enantiomeric separation of cationic drugs and binaphthyl 
derivatives were 25 mM NH4OAc prepared by diluting the 7.5 M NH4OAc stock solution in 
triply DI water and then adjusted from pH 5.0 to 10.8 by acetic acid or ammonium hydroxide, 
respectively. The final running MEKC-ESI-MS/MS buffer solutions were prepared by addition 
of 15 mM or 30 mM polymeric sugar surfactants with different chain length and head group to 
the BGE solutions.   
 
3.2.4 Characterization of β-D-Sugar Surfactants 
The mobility of both monomeric and polymeric sugar surfactants was determined by CE-
MS and CE-UV experiments, respectively using a fused silica capillary with Ld = 60 cm and Lt = 
120 cm.  A mixture of four monomeric sugar surfactants with chain length and head group was 
prepared at a concentration of 5 mM in triply deionized water. This monomer mixture was 
profiled, apparent as well as effective electrophoretic mobility was calculated from migration 
time of CE-MS electropherograms using 25 mM NH4OAc as background electrolyte (BGE) at 
pH 7.0.   Next, the mobility of polymeric sugar surfactants with different chain lengths and head 
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groups was determined by MEKC-UV.  The BGE composition was 25 mM NH4OAc buffer with 
the addition of 15 mM polymeric sugar surfactants in BGE. The mobility of polymeric sugar 
surfactant was traced using 5 mg/mL of Sudan III prepared in 90/10 methanol/water.   
The synthesized monomeric β-D-sugar surfactants with different chain lengths and head 
groups were characterized by using proton nuclear magnetic resonance (1H-NMR) (data shown in 
the supplementary information).   Solutions of a series of concentration from 0.5 mM to 50 mM of 
monomers and polymers were prepared in triply deionized water and their surface tension and 
CMC values were measured by sigma 703 digital tensiometer (KVS Instruments, Monroe, CT, 
USA).  Fluorescence Measurements was conducted on a Perkin Elmer LS 55 Fluorescence 
spectrometer (PerkinElmer Instruments, Norwalk, CA, USA) to determine the aggregation number 
and polarities using pyrene as a probe and cetylpyridinium chloride as a quencher as described 
elsewhere [20]. 
3.3. Results and Discussion 
3.3.1 Physicochemical properties 
The key to synthesizing α or β sugar surfactant anomers with different chain length and 
head group depends on the reaction specified in the first step i.e., the glycosylation step (Scheme 
1) because this reaction takes place at the anomeric carbon site.  Table 3.2 summarizes the 
optimized molar ratio of the boron trifluoride diethyl etherate used and reaction time in 
synthesizing - and -D-undecenyl glucopyranoside surfactants.  Unlike the glycosylation step of 
β-D-glucopyranoside in which 95% of -D-undecenyl glucopyranoside is obtained (Fig.B3 and 
Table 3.2), the glycosylation reaction of β-D-glucose-6-pentacetate yields 99% α-D-undecenyl 
glucopyranoside but only after 72 hrs of reaction time (Fig.B4-B5).  Because the - and -SUGP 
surfactants are diastereomeric they have distinguishable NMR spectra.   For example, the anomeric 
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protons of -SUGP resonates further downfield (4.788-4.779 ppm) from the anomeric beta proton 
(4.271-4.252 ppm) of -SUGP. Thus, the J-J-coupling constant between the two  
anomeric protons of  SUGP and -SUGP were about 3.6 and 7.6 Hz, respectively (Figure B3 
and B5).   
 
 
 
˥ = J= ()(Larmor) (MHz)/106 , the calculations of J,J- coupling constant of α and β anomeric 
proton were shown in supporting information (Fig. S3 and S5) 
 
 
Physicochemical properties of both β-D-glucopyranoside-based surfactant monomers and 
polymers are summarized in Table 3.1. The CMC was determined from surface tension 
measurements, which was used to evaluate the surface activity of all four surfactants with 
increasing molar concentration in water.  As shown in Table 1, the CMC decreases in the 
following order: -SOGS> SOGP>-SUGS-SUGP.  In general a lower CMC is more 
favorable as there will less free monomers, reducing operating currents if unpolymerized micelles 
are used as pseudophase for chiral separations.  The higher CMC of sulfate head groups compared 
to phosphate head groups at equivalent chain length could be possibly explained by the fact that 
Table 3.2. Optimized molar ratio and reaction time for  glycosylation reactions of α- and β-SUGP  
_______________________________________________________________________________ 
  
molar ratio of 
β-D-glucose 
Pentaacetate 
molar ratio of 
Undecylenyl 
alcohol 
molar ratio of 
boron trifluoride 
diethyl etherate  
Reaction 
Time 
(hr) 
J,J- coupling 
constant of 
anomeric 
proton (Hz) 
α-sugar surfactant 1 1.5 5 72 3.6 (99%) 
β-sugar surfactant 1 1.5 1.3 18 7.6 (95%) 
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strong intramolecular hydrogen bonding interactions decreases the repulsion between phosphate 
head groups facilitating micelle formation.  In addition, β-SOGS and β-SOGP have higher CMC 
than β-SUGS and β-SUGP, respectively.  The trend for decreasing CMC with increasing chain 
length is not too surprising as hydrophobicity increases owing to the extension of hydrocarbon 
chain from C8 to C11.  Aggregation number and polarity of both sugar surfactant monomers and 
polymers were measured and determined according to the early work in our group [21].  
Aggregation number increases and polarity decreases with increasing chain length of sugar 
surfactants for both sulfate and phosphate charged on the head groups. 
 
Table 3.1: Physicochemical properties of n-alkenyl β-D-glucopyranoside monomers and 
polymers 
 
monomer polymer 
  
CMC 
(mM)a)  
Aggregation 
#b) 
Polarity 
(I1/I3)c) 
CMC     
(mM)a)  
Aggregation 
#b) 
Polarity 
(I1/I3)c) 
β-SOGP 11 92 1.024 0 70 1.043 
β-SUGP 2.2 110 0.947 0 76 0.941 
β-SOGS 18 84 0.963 0 49 1.011 
β-SUGS 3.7 105 0.932 0 60 0.978 
a) Critical micelle concentration (CMC) is determined by the surface tension measurements 
b) Aggregation number is determined by the florescence quenching experiment using pyrene as a probe and 
cetyl pyridinium chloride as a quencher. 
c) Polarities of the surfactants are determined using ratio of the fluorescence intensity (I1/I3) of pyrene. 
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The effective mobility (µeff) of both monomers and polymers of β-D-alkyl glucopyranoside 
are listed in Table 3. It is worth mentioning that β-SOGP and β-SOGS as well as β-SUGP and β-
SUGS have very similar µeff value. It seems that the sulfate and phosphate charge on the head 
group have little influence on the mobility.  However, increasing the length of carbon chain 
provided some difference in µeff with longer chain surfactants having less negative mobility.  
Furthermore, all four sugar polymeric surfactants have less negative µeff suggesting that MoMs 
provides much larger elution window compared to their corresponding monomers and the longest 
chain MoMs will provide the maximum peak capacity when used as a pseudophase for 
simultaneous separation of parent drug and its metabolites.  Interestingly, the effect of chain length 
of sugar surfactants on elution window seems to be opposite compared to the previous studies on 
amino acid type polymeric surfactants [22].    
 
Table 3.3.  Effective mobility of β-D sugar surfactant monomers and polymers of different head 
group and chain length 
Type of Sugar Surfactant ˥Effective mobility (cm2/(V*s)) 
β-SOGP -0.000615 ± 0.000018 
β-SUGP -0.000604 ± 0.000018 
β-SOGS -0.000619 ± 0.000017 
β-SUGS -0.000606 ± 0.000018 
Poly-β-SOGP -0.000394 ± 0.000011 
Poly-β-SUGP -0.000319 ± 0.000015 
Poly-β-SOGS -0.000383 ± 0.000023 
Poly-β-SUGS -0.000351 ± 0.000014 
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˥ Effective mobility (eff) = a -EOF of all sugar monomers was calculated from the migration 
time or apparent mobility (a) of monomer peak observed in CZE-MS electropherogram and 
mobility of EOF (EOF) observed using methanol as t0 marker via on line CZE-UV-MS on the 
same capillary; effective mobility of all sugar polymers was calculated using methanol as t0 
marker and Sudan III as tmc marker for all sugar polymers in MEKC-UV  
 
 
Figure 3.1 (Panel A and B), shows the effect of mM concentration of eight and eleven 
carbon chain polymeric and monomeric sugar surfactants containing phosphated and sulfated 
charges on the head groups on surface tension.  Two main trends are evident.  First, polymeric 
surfactants (poly--SUGS and poly--SUGP) do not concentrate at the air/water interface and their 
CMC essentially remains zero.  Polymeric surfactants with zero CMC are advantageous compared 
to their unpolymerized micelles in reducing CE-MS operating current.   This is because when 
surfactants are dialyzed after polymerization, the process essentially removes any unreacted 
surfactant monomers.  In addition, much lower concentrations could be used when polymeric 
sufactants are used as pseudostationary phase allowing the operator to easily work under 50 A 
limits. Thus, the polymeric sugar surfactants can be used at lower concentrations without 
compromising enantio-separation. Second, note that both sulfated and phosphated surfactant 
polymers bearing C8 and C11 chain lengths have low surface activity (high surface tension) 
compared to their corresponding monomers.  This suggests that polymers should be more 
beneficial in providing sensitive detection of enantiomeric signal in ESI-MS compared to the 
corresponding low molecular weight monomers [23].  Perhaps, it could be hypothesized that poly-
-SUGP should provide the best LOD as it the most surface active polymer.  Considering the 
above mentioned effects and the data shown in Fig. 1 we evaluated the effect of charge on the head 
group, chain length and anomeric configuration of -D-alkenyl glucopyranoside based surfactants 
for enantioselective MEKC-MS. 
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Fig. 3.1 Plot comparing the surface tension versus concentration of monomers and polymers of 
(A) phosphated surfactants (-SOGP and -SUGP); and (B) sulfated surfactants (-SOGS and -
SUGS).    
 
 
3.3.2 Effect of charge on the head group of β sugar surfactants  
Enantioseparation of  primary, secondary, tertiary and quaternary amines as well as 
amino alcohols (-blockers) and BAI are compared using eleven carbon chain polymeric 
surfactant with sulfated and phosphated charge on the head groups (i.e., poly-β-SUGS (18) and 
poly-β-SUGP (17), Scheme 3.1].   The BGE consisted of 25 mM NH4OAC at the optimized pH 
(A-E) for each analyte.  Even though poly-β-SUGS and poly-β-SUGP have equal number of 
hydrocarbon chain, longer retention times were observed for most compounds on the more polar 
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poly-β-SUGS pseudophase (Table 3.4).  The retention differences between the two phases are 
related to the degree of strength of intermolecular interactions (hydrogen bonding and ion-
pairing) with the type of chiral analyte.   Interestingly, the longer retention time using poly-β-
SUGS does not always resulted in higher Rs and Navg for most of the chiral compounds studied.  
For example, the more polar, poly-β-SUGS phase did not enantioseparate as many positively 
charged compounds when compared to poly-β-SUGP.  Significantly higher enantioresolution 
was observed with the later surfactant for primary and secondary amines as well as amino 
alcohols (Table 3.4).  These results suggest that the enhanced chiral selectivity on poly-β-SUGP 
compared to poly-β-SUGS for the aforementioned chiral analytes is perhaps due to structural 
rigidity of the phosphate charge substitution with respect to glucose ring, which in turn promotes 
stronger chiral interactions with oppositely charged analytes. On the other hand, the sulfate 
charge on the glucose ring has more flexible orientation in poly-β-SUGS surfactant.   However, 
in Table 3.4, there are several noted exceptions, and ~ one third (i.e., 8 out of 25) of chiral 
compounds are resolved better with poly-β-SUGS.   Further, the data in Table 3.4 reveals that 
majority of investigated BAI (i.e.,5 out of 6)  are better separated with poly-β-SUGS compared 
to poly-β-SUGP.   
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Table 3.4:  Effect of head group on resolution (Rs), migration time (tr2), selectivity (a) and 
efficiency (Navg) of 25 enantiomeric compounds using poly β-n-undecyl glucopyranoside 
surfactant pseudophases 
 
Compound name      PSP  Rs 
tr2 
(min) Navg α ˥BGE 
norephedrine 
β-SUGP 1.8 33.0 47,000 1.02 A1 
β-SUGS 1.6 32.2 36,000 1.02 A2 
pseudoephedrine 
β-SUGP 1.5 29.8 56,000 1.02 A1 
β-SUGS 2.4 37.9 87,000 1.04 A2 
ephedrine 
β-SUGP 2.0 32.3 66,000 1.02 A1 
β-SUGS 1.5 37.4 46,000 1.01 A2 
methylephedrine 
β-SUGP 2.1 32.0 54,000 1.04 A1 
β-SUGS 2.0 43.3 46,000 1.03 A2 
pindolol 
β-SUGP 0.5 21.8 6,300 1.01 B1 
β-SUGS 0.0 27.7 3,000 1.00 B2 
alprenolol 
β-SUGP 0.5 44.9 6,000 1.01 B1 
β-SUGS 0.0 27.7 4,800 1.00 B2 
metoprolol 
β-SUGP 0.4 16.6 69,000 1.01 B1 
β-SUGS 0.2 24.8 61,000 1.01 B2 
nadolol 
β-SUGP 
3.5      
1.8 21.5 
25,000                   
20,000 
1.12       
1.04 B1 
β-SUGS 
2.7          
0.0 18.6 
24,000   
10,000 
1.12       
1.00 B2 
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octopamine 
β-SUGP 1.8 12.8 10,000 1.02 B3 
β-SUGS 0.5 8.7 8,000 1.01 B4 
isoproterenol 
β-SUGP 2.0 9.5 2,000 1.03 A3 
β-SUGS 0.0 10.8 1,500 1.00 A4 
terbutaline 
β-SUGP 2.1 9.4 13,000 1.04 D1 
β-SUGS 1.5 14.7 11,000 1.03 B4 
bupivicaine 
β-SUGP 1.4 17.8 16,000 1.03 A3 
β-SUGS 0.0 15.2 10,000 1.00 D2 
3-
pinanemethylamine 
β-SUGP 0.3 22.4 39,000 1.01 B3 
β-SUGS 0.0 23.4 35,000 1.00 D2 
normetanephrine 
β-SUGP 1.8 7.2 4,000 1.06 B3 
β-SUGS 0.0 6.6 1,100 1.00 D2 
Atropine  
β-SUGP 0.0 16.3 1,000 1.00 A3 
β-SUGS 1.5 46.5 7,200 1.03 A4 
Homatropine 
β-SUGP 5.0 10.0 12,000 1.52 A3 
β-SUGS 1.5 13.5 7,500 1.04 D2 
norphenylephrine 
β-SUGP 2.0 13.8 10,000 1.03       B3 
β-SUGS 0.1 10.7 7,000 1.01       A4 
synepherine 
β-SUGP 1.4 16.5 7,300 1.05 A3 
β-SUGS 0.0 9.4 5,000 1.00 A4 
Aminoglutethimide 
β-SUGP 0.0 9.3 1,000 1.00 A3 
β-SUGS 0.3 16.0 8,000 1.01 A4 
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˥All BGE contains 25 mM NH4OAc.  A1: 30 mM poly β-SUGP, pH 5; A2: 30 mM poly β-
SUGS, pH 5; A3: 15 mM poly β-SUGP, pH 5; A4: 15 mM poly β-SUGS, pH 5; B1: 30 mM poly 
β-SUGP, pH 7; B2: 30 mM poly β-SUGS, pH 7; B3: 15 mM poly β-SUGP, pH 7; B4: 15 mM 
poly β-SUGS, pH 7; C: 15 mM poly β-SUGS, pH 6; D1: 15 mM poly β-SUGP, pH 9; D2: 15 
mM poly β-SUGS, pH 9; E: 15 mM poly β-SUGP, pH 10.8 
 
 
 
BNP 
β-SUGP 4.5 25.3 23,000 1.10 D1 
β-SUGS 5.0 29.7 24,000 1.20 C1 
1-(2-amino-3-chloro-
6-methylphenyl) 
naphthalen-2-ol 
β-SUGP 
1.0      
0.2 13.6 
25,000     
22,000 
1.02    
1.01 E1 
β-SUGS 
1.5     
1.4 39.4 
17,000  
15,000 
1.04      
1.03 C1 
1-(2-amino-3-chloro-
5-methylphenyl) 
naphthalen-2-ol 
β-SUGP 
1.0      
0.2 13.6 
25,000   
22,000 
1.02    
1.01 E1 
β-SUGS 
1.5     
1.4 39.4 
17,000    
15,000 
1.04      
1.03 C1 
1,1'-binaphthalene-
2,2'-diamine 
β-SUGP 0.2 21.0 5,300 1.00 B3 
β-SUGS 0.0 22.5 4,800 1.00 E1 
BOH  
β-SUGP 1.5 13.6 8,500 1.04 E1 
β-SUGS 3.5 45.7 10,000 1.10 C1 
1-(2-amino-3-
bromophenyl)-6- 
methoxynaphthalen-
2-ol 
β-SUGP 0.2 20.0 14000 1.01 E1 
β-SUGS 1.5 42.1 33,000 1.03 C1 
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Fig. 3.2 shows a complementary chiral effect for sulfate and phosphate charge on the 
head group of the polymeric surfactant for two structurally similar quaternary amines (atropine 
and homatropine). Both atropine and homatropine are used as eye dilator before eye 
examinations, before and after eye operation, and for treatment of eye conditions (e.g., uveitis or 
posterior synechiae) [24].  Note that atropine has a chiral center one carbon atom away from the 
hydroxyl group whereas in case of homatropine chiral center is located next to the hydroxyl 
group.  Thus, poly-β-SUGS gave baseline enantioseparation for atropine, while poly-β-SUGP 
provided no enantioseparation for atropine.  This could be possibly due to steric hindrance of 
extra methylene group) in atropine structure, which possibly made it harder to interact with the 
rigid phosphate charge on the sugar head group.  On the other hand, the chiral Rs of homatropine 
is achieved by both chiral surfactants.   However, with poly-β-SUGP the Rs is 5.0, which is 
much higher than 1.7 realized by the sulfate charge on the head group of poly-β-SUGP.    
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Fig. 3.2  Electropherograms comparing the effect of head group of polymeric sugar surfactants 
on chiral separation of atropine and homatropine in MEKC-MS/MS.   Conditions: 25 mM 
NH4OAc, pH 5.0, using 15 mM poly-β-SUGS (left) and poly-β-SUGP (right).  Sample 
concentration: 100 µg/mL in MeOH/H2O (10/90, v/v).   Other conditions are the same as 
discussed in section 3.2.3.1. 
 
 
3.3.3 Effect of chain length of β-D sugar surfactants  
Separation of multichiral center drug is a special challenge due to complex structure of 
these analytes.  Fig. 3.3(A-D) shows the comparisons of the chiral Rs of nadolol, 5-{3-[1,1-
dimethylethyl amino]-2-hydroxypropoxy}1,2,3,4-tetrahydro-cis-2,3-naphthalene diol.  As Figure 
3 inset shows nadolol is a non-selective -blocker, which contains four stereoisomers.  Although 
nadolol has three chiral centers, only four stereoisomers are possible because the two adjacent 
hydroxyl groups on the cyclohexane ring are conformationally locked.  This chiral compound is 
useful for the treatment of hypertension and angina pectoris.  Comparing Fig. 3.3A vs. Fig.3.3B, 
it can be seen that migration time as well resolution of stereoisomers of nadolol increases with 
100 
the increase in chain length of the sulfated surfactants with total analysis time increased from 9 
to 19 min.  No chiral Rs for nadolol was observed for poly-β-SOGS while partial Rs was 
obtained by poly-β-SUGS.   In contrast, increase in run time from 7 to 22  min in Fig. 3.3C vs. 
Fig. 3.3D provided significant improvement resulting in baseline resolution of all four 
stereoisomers using  C11 phosphated (i.e., poly--SUGP) compared to C8 phosphated (i.e., poly-
-SOGP) surfactant. Perhaps, nadolol, penetrates less inside the hydrophobic micellar core of 
poly-β-SOGS and poly-β-SOGP, resulting in faster migration time and poorer Rs.  
 
 
 
 
 
 
 
 
 
 
Fig. 3.3 Electropherograms comparing the effect of chain length of polymeric sugar surfactants 
on chiral separation of nadolol in MEKC-MS/MS. Conditions: 25 mM NH4OAc, pH 5.0, using 
30 mM (A) poly-β-SOGS,   (B) poly-β-SUGS, (C) poly-β-SOGP and (D) poly-β-SUGP.   
Sample concentration: 100 µg/mL in MeOH/H2O (10/90, v/v).   Other conditions are the same as 
discussed in section 3.2.3.1. 
 
 
In contrast to separation of multichiral center -blocker (nadolol), enantioseparation of 
single chiral center -blockers (metoprolol, alprenolol and pindolol) is not significantly enhanced 
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with the increase in chain length (Table 3.5).  However, enhanced separation of primary and 
secondary amines was mostly observed with longer chain length surfactants.  Interestingly, 
benzodiazepines only showed some indication for enantioresolution but with only one polymeric 
surfactant, i.e., short chain, poly-β-SOGP.  The BAI were best enantioseparated using shorter 
chain phosphated surfactants compared to longer ones with the same head group.    For example, 
poly-β-SOGP separates 6 out of 8 BAI (last 8 rows, Table 3.5) better than the remaining three 
polymeric surfactants.  This shows that less hydrophobic interactions of shorter chain surfactant 
is sometimes more favorable and cannot be neglected as it can enhance hydrogen bond 
interactions of the analyte with the charge on the surfactant head group.  Nevertheless, this trend 
shows that the chiral recognition mechanism in polymeric sugar surfactants cannot be simply 
reduced to one type of interaction, rather it involves several types.  Thus, this new generation of 
polymeric surfactants are particularly effective and versatile. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.5:  Effect of chain length on resolution (Rs), migration ime (tr2), selectivity (a) and 
efficiency (Navg) of enantiomeric compounds using poly β-n-undecyl glucopyranoside surfactant 
pseudophases 
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Compound name      PSP  Rs tr2 (min) Navg α 
˥BGE 
norphenylephrine 
β-SUGP 2.0 13.8 10,000 1.03 A3 
β-SUGS 0.1 10.7 7,000 1.01 A4 
β-SOGP 1.5 6.2 7,000 1.05 D3 
β-SOGS 0.0 5.8 2,000 1.00 D4 
octopamine 
β-SUGP 1.8 12.8 10,000 1.02 B5 
β-SUGS 0.5 8.7 8,000 1.01 B6 
β-SOGP 1.5 6.1 10,000 1.07 D3 
β-SOGS 0.0 5.9 2,300 1.00 D4 
pindolol 
β-SUGP 0.5 21.8 6,300 1.01 B1 
β-SUGS 0.0 27.7 3,000 1.00 B2 
β-SOGP 0.6 44.8 26,000 1.01 B3 
β-SOGS 0.0 13.5 5,900 1.00 B4 
alprenolol 
β-SUGP 0.5 44.9 6,000 1.01 B1 
β-SUGS 0.0 27.7 4,800 1.00 B2 
β-SOGP 0.6 44.9 24000 1.00 B3 
β-SOGS 0.0 13.5 5,900 1.00 B4 
metoprolol 
β-SUGP 0.4 16.6 69,000 1.01 B1 
β-SUGS 0.2 24.8 61,000 1.01 B2 
β-SOGP 0.5 31.0 46,000 1.01 B3 
β-SOGS 0.0 11.7 13,000 1.00 B4 
propranolol 
β-SUGP 0.0 41.6 7,000 1.00 B1 
β-SUGS 0.0 28.9 11,000 1.00 B2 
β-SOGP 0.1 39.2 110,000 1.01 B3 
β-SOGS 0.1 22.8 150,000 1.00 B4 
3-pinanemethylamine 
β-SUGP 0.3 22.4 39,000 1.01 B5 
β-SUGS 0.0 23.4 35,000 1.00 D2 
β-SOGP 0.1 10.2 12,000 1.01 A5 
β-SOGS 0.0 15.0 3,000 1.00 D4 
oxazepam 
β-SUGP 0.0 17.7 5,000 1.00 D1 
β-SUGS 0.0 18.0 4,300 1.00 D2 
β-SOGP 0.0 11.8 700 1.00 A1 
β-SOGS 0.1 17.6 16,000 1.00 A2 
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temazepam 
β-SUGP 0.0 15.0 2,100 1.00 D1 
β-SUGS 0.0 16.9 9,300 1.00 D2 
β-SOGP 0.0 10.6 700 1.00 D3 
β-SOGS 0.3 16.3 26,000 1.01 D4 
lorazopam 
β-SUGP 0.0 18.7 3,900 1.00 D1 
β-SUGS 0.0 19.1 5,800 1.00 D2 
β-SOGP 0.0 13.2 600 1.00 A1 
β-SOGS 0.7 20.1 9,000 1.04 A2 
BNP 
β-SUGP 4.5 25.3 23,000 1.10 D1 
β-SUGS 5.0 29.7 24,000 1.20 C1 
β-SOGP 7.8 52.9 30,000 1.13 A1 
β-SOGS 9.4 64.8 31,000 1.37 A2 
BOH 
β-SUGP 1.5 13.6 8,500 1.04 E1 
β-SUGS 3.5 45.7 10,000 1.10 C1 
β-SOGP 2.5 20.9 18,000 1.07 E3 
β-SOGS 1.5 16.4 13,000 1.04 E4 
1,1'-binaphthalene-
2,2'-diamine 
β-SUGP 0.2 21.0 5,300 1.00 B5 
β-SUGS 0.0 22.5 4,800 1.00 E2 
β-SOGP 0.2 20.7 18,000 1.01 E3 
β-SOGS 0.0 17.1 7,300 1.00 E4 
1-(2-amino-3-chloro-
6-methylphenyl) 
naphthalen-2-ol 
β-SUGP 
1.0     
0.2 13.6 
29,000 
26,000 
1.02    
1.01 E1 
β-SUGS 
1.5     
1.4 39.4 
13,000 
11,000 
1.04    
1.03 C1 
β-SOGP 
2.2    
1.6 16.8 
37,000 
31,000 
1.05    
1.04 E3 
β-SOGS 
0.9     
0.0 20.4 
26,000    
11,000 
1.01    
1.00 B7 
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1-(2-amino-3-chloro-
5-methylphenyl) 
naphthalen-2-ol 
β-SUGP 
1.1      
0.2 13.6 
37,000 
29,000 
1.02    
1.01 E1 
β-SUGS 
1.5    
1.4 39.4 
12,000 
11,000 
1.04     
1.03 C1 
β-SOGP 
2.2    
1.7 19.1 
37,000 
36,000 
1.05     
1.04 E3 
β-SOGS 
0.7    
0.0 23.9 
19,000         
11,000 
1.01    
1.00 B7 
1-(2-amino-3-bromo-
4-methylphenyl) 
naphthalen-2-ol 
β-SUGP 0.0 15.2 22,000 1.00 E1 
β-SUGS 0.0 20.7 8,500 1.00 E2 
β-SOGP 1.7 20.9 27,000 1.03 E3 
β-SOGS 0.0 16.5 8,900 1.00 E4 
1-(2-amino-3-
bromophenyl)-6- 
methoxynaphthalen-
2-ol 
β-SUGP 0.2 20.0 14,000 1.01 E1 
β-SUGS 1.5 42.1 33,000 1.03 C1 
β-SOGP 1.9 20.1 39,000 1.04 E3 
β-SOGS 0.1 15.9 25,000 1.00 E4 
1-(2-amino-3,4,5-
trichlorophenyl) 
naphthalen-2-ol 
β-SUGP 0.0 16.3 11,000 1.00 E1 
β-SUGS 0.0 23.2 5,100 1.00 E2 
β-SOGP 0.2 25.6 46,000 1.01 E3 
β-SOGS 0.1 23.9 11,000 1.01 E4 
 ˥All BGE contains 25 mM NH4OAc.  A1: 15 mM poly β-SOGP, pH 5; A2: 15 mM poly  
  β-SOGS,  pH 5; A3: 15 mM poly β-SUGP, pH 5; A4: 15 mM poly β-SUGS, pH 5; A5: 15 mM  
  poly β-SOGP,pH 5; B1: 30 mM poly β-SUGP, pH 7; B2: 30 mM poly β-SUGS, pH 7; B3: 30 
mM poly β-SOGP, pH 7; B4: 30 mM poly β-SOGS, pH 7; B5: 15 mM poly β-SUGP, pH 7; B6: 
15 mM poly β-SUGS, pH 7; B7: 15 mM poly β-SOGS, pH 7; C1: 15 mM poly β-SUGS, pH 6;  
D1: 15 mM poly β-SUGP, pH 9; D2: 15 mM poly β-SUGS, pH 9; D3: 15 mM poly β-SOGP, pH 
9; D2: 15 mM poly β-SOGS, pH 9; E1: 15 mM poly β-SUGP, pH 10.8; E2: 15 mM poly β-SUGS, 
pH 10.8; E3: 15 mM poly β-SOGP, pH 10.8; E4: 15 mM poly β-SOGS, pH 10.8; 
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3.3.4 Optimized eantioseparations of cationic compounds and biaryl atropisomers  
Fig. 3.4A shows the electropherograms of 21 cationic chiral compounds enantioresolved 
by -D sugar surfactants using optimum head group and optimum chain length at their respective 
optimized pH.  Almost half of the cationic compounds were best enantioseparated by poly-β-
SUGP.  Besides the longer chain length of poly-β-SUGP, which enables the analytes to 
participate more with the hydrophobic core of polymeric sugar micelles, we hypothesize that this 
is probably due to enhanced attractive interaction, (e.g., electrostatic and hydrogen bonding) 
between the amine moiety of the analytes and the rigid bicyclic structure of the phosphate head 
group.   
The enantioseparations of 8 BAIs using the optimized head group and optimized chain 
length of polymeric -D-sugar surfactant at pH 10.8 are shown in Fig. 3.4B.   Interestingly, 
majority of the BAIs were better separated by short chain polymeric surfactants.  For example, 5  
out of 8 atropisomers were better enantioseparated by C8 chain, poly-β-D-SOGP compared to C11 
chain poly-β-SUGP (analyte 14-18, Table 3.5, Figure 3.4B ).  The only exception was (+/-) BNA 
which enantioseparated best with the longer chain polymeric surfactant but provided only partial 
resolution. Similarly, C8 chain, poly-β-SOGS provided the highest resolution value (Rs = 9.4) for 
the enantiomeric separation of (+/-)- BNP,  and this was the only polymeric surfactant, which 
provided a hint of chiral resolution for difficult to separate enantiomers of  1-(2-amino-3,4,5-
trichlorophenyl) naphthalen-2-ol.  Overall, it appears that the chiral recognition for BAI seems to 
be dominated by short chain polymeric surfactants, which are weakly hydrophobic.    
Screening of a total of 43 chiral compounds including 35 cationic compounds and 8 BAI 
using four -D polymeric sugar surfactants with different head groups and chain lengths (Fig. 
3.5) reveals that poly-β-SUGP offered the highest success rate for chiral Rs (53%), in which 35% 
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of the analytes had excellent chiral Rs (Rs>1.5). The eleven carbon chain, poly-β-SUGS 
provided the second best success rate (44%) in which 28% of the analytes had chiral Rs higher 
than 1.5. Among all 43 compounds, 30 analytes were enantioresolved using these four polymeric 
sugar surfactants and the overall success rate of analytes resolved was 70%. 
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Fig. 3.4 MEKC-MS of (A) 21 resolved cationic compounds and (B) 8 binaphthyl derivatives 
using four sugar surfactants using the optimum head group and optimum chain length of 
polymeric sugar surfactants.   Buffer conditions:  25 mM NH4OAc was used as BGE in all 
separations,  pH 5, 30 mM poly--SUGP (A1); pH 7, 30 mM poly--SUGP (A2); pH 5, 15 mM 
poly--SUGP (A3) pH 6, 15 mM poly--SUGP (A4) pH 7, 15 mM poly--SUGP (A5);  pH 5, 
30 mM poly--SUGS (C1);  pH 5, 15 mM poly--SUGS (C2); pH 5, 15 mM poly--SOGS (D);  
pH 10.8 with 15 mM poly--SOGP (B);  pH 10.8, 15 mM poly--SOGS (D2); Sample 
concentration: 100 µg/mL in MeOH/H2O (10/90, v/v), Other conditions are the same as in Fig. 
3.2.  
 
 
 
 
 
 
 
 
 
 
Fig. 3.5 Bar plots showing the chiral resolution values from the chiral screening using sugar 
surfactant polymers with different head groups and chain lengths. The Rs values are classified as 
poor (Rs = 0), fair-to-good (0 < Rs < 1.5), and excellent (Rs > 1.5).   
 
 
3.3.5 Comparison of α- and β- sugar surfactants  
The only difference between α- and β-glucopyranoside based surfactants is the anomeric 
orientation of the hydrocarbon chain with respect to the glucopyranoside ring.   However, α-D 
and β-D sugar surfactant exhibit distinct structural differences according to earlier study on the 
molecular modeling of C14- chain of D-glucopyranoside [25].  
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 Fig. 3.6 (A-D) represents comparison of α- and β-glucopyranoside based polymeric 
surfactants using the same BGE conditions for chiral separations of pseudoephedrine and 
metoprolol. Poly-β-SUGP provided baseline enantioseparation of pseudoephedrine, while 
pseudoephedrine was partially enantioresolved using -form of the same polymer.  Interestingly, 
complementary effect was observed when poly-α-SUGP provided higher chiral Rs for 
metoprolol compared to poly- β-SUGP.   This complementary effect could be possibly due to the 
different surface distribution of electrostatic potential for α- and β-configuration. The β-micelles 
contain more negative potential on the phosphate head group surface, which enabled stronger 
attraction with the positively charged hydrophilic analyte such as pseudoephedrine  (log P = 1.05 
) resulting in baseline Rs. However, since metoprolol (log P = 1.88) is more hydrophobic than 
pseudoephedrine, it penetrates deeper in the micellar core of poly--SUGP.  Similar trend to 
metoprolol was observed for talinolol (log P = 3.20), the most hydrophobic among all three. 
Thus, -form of SUGP was superior to -form as a chiral selector for this class of chiral 
compounds.    
The bar plots shown in Fig. 3.6E provides a comparison of enantioseparation of ~30-40 
chiral compounds between poly-α-SUGP and poly-β-SUGP. While more chiral compounds 
were screened with poly-β-SUGP and this polymer exhibited an overall higher success rate of 
53% compared to 47% success rate observed with poly-α-SUGP.  Clearly, there is a 
complementary trend.  For example, most cationic chiral compounds which were separated 
better by poly-α-SUGP were relatively more hydrophobic suggesting that the chiral recognition 
is more likely related to hydrophobicity of the analyte with hydrophobic charged analyte 
separates better with poly-α-SUGP.    
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Fig. 3.6 Electropherograms comparing the effect of anomeric configuration of 30 mM polymeric 
phosphated sugar on the enantioseparation of (A-B) pseudoephedrine and (C-D) metoprolol in 
MEKC-MS/MS.   Buffer: 25 mM NH4OAc, pH 5.0 and 7.0 for pseudoephedrine and metoprolol,  
respectively.  Sample concentration: 100 µg/mL in MeOH/H2O (10/90, v/v).  Other conditions 
are the same as Fig.3.2. The bar plots in (E) showing the chiral resolution values from the chiral 
screening using sugar surfactant polymers with different anomeric configurations. The Rs values 
are classified as poor (Rs = 0), fair-to-good (0 < Rs < 1.5), and excellent (Rs > 1.5).   
 
 
3.3.6 Multiplexed analysis   
Multisegment injection in CE-MS  is an emerging tool for high-throughput analysis of 
drugs and metabolites, in which serial hydrodynamic injection of multiple segments of sample 
111 
are performed within one single run without sacrificing chiral Rs [26].   Such a system has been 
proposed recently for metabolomics [6], but this is a first time chiral MEKC-MS has been used 
to support such a scenario.  The advantage of using multisegment injection was utilized to 
acquire a four point calibration curve of BNP standard (100 to 500 µg/mL) and the R-BOH as I.S 
in MEKC-MS (Fig. 3.7). The spacer (i.e., BGE containing molecular micelle) segments were 
studied over a range of injection time from 80 sec to 240 sec to optimize the eantioseparations of  
BNP and I.S (i.e., BOH). The longer segment such as 200 sec was found to be beneficial for the 
separation of I.S but BNP exhibited partial peak overlap with this segment time.  In contrast, 
shorter spacer segments of 80s provided better chiral Rs for BNP, whereas I.S cannot be 
separated (Fig. B20, Supporting Information).   Therefore, 120 sec was found to be the best 
trade-off for the simultaneous enantiosepation of BNP from the separation of I.S. However, the 
use of EIC mode allows simultaneous determination of peak areas.  Overall, good linearity of 
both R- and S-BNP was demonstrated (R2 > 0.990) using multisegment injection MEKC-MS, 
which opens up the possibility to quantitate the two isomers in biological matrix efficiently. 
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Fig. 3.7 Multiplexed enantioseparation of 1, 1’-binaphthyl phosphate (BNP) using serial dilution 
of four discrete sample segments with concentrations of 1,1’= 100 ug/mL, 2,2’ = 200 ug/mL , 
3,3’= 300 ug/mL and 4,4’ = 500 ug/mL (bottom electropherogram)  at fixed concentration (250 
ug/ml) of  R-binaphthol as an internal standard (top electropherogram) in a single run using an 
optimum micelle spacer of 5mbar, 120s. Buffer: 25 mM NH4OAc, pH 5.0, 15 mM SUGS.  The 
Fig 6 inset shows a calibration curve for a single step acquisition of four point calibration linear 
over the range of 100 µg/mL to 500 µg/mL.  Other conditions are the same as discussed in 
section 3.2.3.1. 
 
 
3.4. Conclusions  
Four polymeric β-D-glucopyranoside based surfactants were successfully synthesized, 
characterized, polymerized and screened for enantioselective MEKC-MS.   Sulfate and 
phosphate charge on the head group polymeric surfactants with C11 carbon chain showed 
complementary chiral separations of cationic amines.   On the other hand, shorter chain length 
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phosphated surfactants (e,g., poly--D-SOGP) exclusively separate majority of the BAI.  
Nevertheless, either too strong or too weak hydrophobic interactions between sugar micelle 
polymer and the chiral analyte leads to poor Rs.  Thus, it is important to have proper 
hydrophobic–hydrophilic balance between polymeric sugar surfactants and the analytes to 
achieve good Rs. Overall, enantiomeric separations of 30 out of 43 chiral compounds (70% 
successful rate) were realized by using β-D-glucopyranoside based surfactants with different 
chain lengths and head groups in MEKC-MS/MS.  
 The α- and β-SUGP exhibits complementary behavior in enantioseparation of amines 
(e.g., secondary amines (pseudoephedrine) vs. amino alcohols (metoprolol). Further detailed 
exploration in the chiral recognition of α-D and β-D configuration of glucopyranoside surfactant 
is warranted for better understanding of chiral recognition mechanism with this new generation 
of MS compatible polymeric surfactants.  Finally, multiplexed quantitative analysis of R/S-BNP 
using multisegment injection MEKC-MS demonstrates the feasibility of high throughput 
quantitation of enantiomers, which could be applied convenienty for analysis of biological 
samples.  
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Figure A1. 1H-NMR spectrum of Product 2, n-undecenyl α-D-glucopyranoside, pentaacetate in 
CDCl3 
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Figure A2. 1H-NMR spectrum of Product 3, n-undecenyl α-D-glucopyranoside in MeOD 
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Figure A3. 1H-NMR spectrum of Product 4, n-undecenyl α-D-glucopyranoside 4,6-phenyl 
phosphate in CDCl3 
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Figure A4. 1H-NMR spectrum of n-undecenyl α-D-glucopyranoside 4,6-hydrogen phosphate, 
sodium salt in D2O 
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Figure A5. 1H-NMR spectrum of n-octenyl α-D-glucopyranoside 4,6-hydrogen phosphate, 
sodium salt in D2O 
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Figure A6. 1H-NMR spectrum of n- undecenyl α-D-glucopyranoside 6-hydrogen sulfate, 
monosodium salt in D2O 
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Figure A7. 1H-NMR spectrum of n-octenyl α-D-glucopyranoside 6-hydrogen sulfate, 
monosodium salt in D2O 
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Figure A8. ESI-MS of sugar surfactants in negative mode  
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-
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Table A1. Limit of detection (LOD) chromatogram of BNP, ephedrines and β-blockers in 
MEKC-MS/MS  
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Scheme B1 Synthesis scheme for  poly(n-undecyl β-D-glucopyranoside 4,6-hydrogen phosphate, 
sodium salt 9) (poly--SUGP), poly(n-undecyl β-D-glucopyranoside 6-hydrogen sulfate, 
monosodium salt 13) (poly--SUGS),  poly-(n-octyl -D-glucopyranoside 4,6-hydrogen 
phosphate, sodium salt 8), (poly--SOGP),  poly(n-octyl -D-glucopyranoside 6-hydrogen 
sulfate, monosodium salt 12) (poly--SOGS).    
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Figure B1. 1H-NMR of  Compound 4, n-octenyl β-D-glucopyranoside in MeOD 
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Figure B2. 1H-NMR of  Compound 5, n-undecenyl β-D-glucopyranoside in MeOD 
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Figure B3. 1H-NMR of α and β ratio of Compound 5 n-undecenyl β-D-glucopyranoside  
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Figure B4. 1H-NMR of Compound 15 n-undecenyl α-D-glucopyranoside in MeOD 
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Figure B5. 1H-NMR of α and β ratio of Compound 15 n-undecenyl α-D-glucopyranoside  
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Figure B6. 1H-NMR of Compound 6, n-octenyl β-D-glucopyranoside 4,6-phenyl phosphate in 
CDCl3 
 
 
 
 
 
 
 
2
6
101
12
8
79
O
O
OH
OH
O
P
O
O
O
13
14
1
3
4
5
[  ]
15
16
17
18
H
H
15,16,17,18
2
1,3 9
12,14
8,13
10,11
5,4
6
7
135 
 
 
 
 
Figure B7. 1H-NMR of  Compound 7, n-undecenyl β-D-glucopyranoside 4,6-phenyl phosphate 
in CDCl3 
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Figure B8. 1H-NMR of  Final Product 8 n-octenyl β-D-glucopyranoside 4,6-hydrogen 
phosphate, sodium salt in D2O 
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Figure B9. 1H-NMR of  Final Product 9 n-undecenyl β-D-glucopyranoside 4,6-hydrogen 
phosphate, sodium salt in D2O 
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Figure B10. 1H-NMR of Compound 10, n-octenyl β-D-glucopyranoside 6-hydrogen sulfate in 
D2O 
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Figure B11. 1H-NMR of Compound 11 n-undecenyl β-D-glucopyranoside 6-hydrogen sulfate 
in D2O 
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Figure B12. 1H-NMR of final product Compound 12,  n-octenyl β-D-glucopyranoside 6-
hydrogen sulfate, monosodium salt in D2O 
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Figure B13. 1H-NMR of  final product Compound 13, n-undecenyl β-D-glucopyranoside 6-
hydrogen sulfate, monosodium salt in D2O 
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Figure B14.  1H-NMR of Compound 16,  n-undecenyl α-D-glucopyranoside 4,6-hydrogen 
phosphate, sodium salt in D2O 
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Figure B15.  1H-NMR of Compound 17,  poly n-undecyl β-D-glucopyranoside 4,6-hydrogen 
phosphate, sodium salt in D2O 
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Figure B16. 1H-NMR of  Compound 18, poly n-undecyl β-D-glucopyranoside 6-hydrogen 
sulfate, monosodium salt in D2O 
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Figure B17.  1H-NMR of Compound 19,  poly n-octyl  β-D-glucopyranoside 4,6-hydrogen 
phosphate, sodium salt in D2O 
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Figure B18. 1H-NMR of  Compound 20, poly n-octyl β-D-glucopyranoside 6-hydrogen sulfate, 
monosodium salt in D2O 
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Figure B19.  1H-NMR of Compound 21, poly n-undecyl α-D-glucopyranoside 4,6-hydrogen 
phosphate, sodium salt in D2O 
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Figure B20. Optimization of spacer segments in Multiplexed MEKC-MS/MS 
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Analyte 
Rs  Navg 
MRM 
transition 
Norephedrine   
1.8  47000 152.2 →  117.0 
pseudoephedrine 
2.4 87000 166.1 → 115.1 
ephedrine 
1.6 46000 166.1 → 115.1 
methylephedrine 
2.1 25000 180.2  → 147.2 
pindolol 
0.5 6300 249.2 → 116.2 
alprenolol 
0.5 6000 250.2 → 116.2 
metoprolol 
0.4 3700 268.2  →  116.2 
talinolol 
0.1 4800 364.3 → 308.3 
nadolol 
Rs1:3.5,  Rs2: 1.8 
N1avg: 25000 
N2avg: 20000 310.2→ 254.1 
octopamine 
1.8 1400 154.1 → 136.1 
isoproterenol  
2 2000 212.1→ 194.2 
terbutaline 
2.1 2900 226.1→ 152.1 
bupivacaine 
1.4 16000 289.2→ 140.2 
3-pinanemethylamine  
0.3 21000 168.2→ 151.2 
normetanephrine 
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Table B1. Chiral separations of cationic compounds and binaphthyl derivatives 
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Atropine sulfate 
1.5 7200 290.2→ 124.2 
Homatropine  
5 1200 276.2→ 124.2 
Oxazepam 
 
 
 
0.1 1900 287.1 → 240.9 
temazepam 
0.3 2000 301.1 → 254.9 
Lorazepam 
 
 
0.7 1700 321.233.0 → 274.9 
Norphenylephrine  
2 1200 154.1→ 91.1 
Synepherine   
 
 
1.4 3300 168.1→ 77.1 
Aminoglutethimide 
 
 
 
0.3 1000 233.1 →146.0 
1,1′-Binaphthyl-2,2′-diyl  
hydrogenphosphate  
                                                                             
 
9.4 6200 347.1→ 79.1 
1-(2-amino-3-chloro-6-methylphenyl) 
naphthalen-2-ol 
Rs1: 2.4, Rs2: 2.0 
N1avg: 9000, 
N2avg: 19000 282.1→ 264.0 
1-(2-amino-3-chloro-5-methylphenyl) 
naphthalen-2-ol 
Rs1: 2.4, Rs2: 2.0 
N1avg:1000,  
N2avg: 18000 282.1→ 264.1 
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1,1'-binaphthalene-2,2'-diamine 
0.2 1200 283.1→ 266.1 
1,1'-Bi-2-naphthol  
3.5 6000 285.1→ 267.1 
1-(2-amino-3-bromo-4-methylphenyl) 
naphthalen-2-ol 
1.7 21000 326.0→308.0 
1-(2-amino-3,4,5-trichlorophenyl) 
naphthalen-2-ol 
0.1 1400 336.0→318.0 
1-(2-amino-3-bromophenyl)-6- 
methoxynaphthalen-2-ol 
1.9 36000 342.0→309.0 
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